JNK	B-protein
(	O
c-Jun	B-protein
NH2-terminal	I-protein
kinase	I-protein
)	O
is	O
a	O
target	O
for	O
antioxidants	O
in	O
T	B-cell_type
lymphocytes	I-cell_type
.	O

AP-1	B-protein
has	O
been	O
shown	O
to	O
behave	O
as	O
a	O
redox-sensitive	B-protein
transcription	I-protein
factor	I-protein
that	O
can	O
be	O
activated	O
by	O
both	O
oxidant	O
and	O
antioxidant	O
stimuli	O
.	O

However	O
,	O
the	O
mechanisms	O
involved	O
in	O
the	O
activation	O
of	O
AP-1	B-protein
by	O
antioxidants	O
are	O
largely	O
unknown	O
.	O

In	O
this	O
study	O
we	O
show	O
that	O
the	O
structurally	O
unrelated	O
antioxidant	O
agents	O
pyrrolidine	O
dithiocarbamate	O
(	O
PDTC	O
)	O
,	O
butylated	O
hydroxyanisole	O
,	O
and	O
Nacetylcysteine	O
activated	O
JNK	B-protein
(	O
c-Jun	B-protein
NH2-terminal	I-protein
kinase	I-protein
)	O
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
.	O

This	O
activation	O
differed	O
substantially	O
from	O
that	O
mediated	O
by	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)	O
and	O
Ca2+	O
ionophore	O
or	O
produced	O
by	O
costimulation	O
with	O
antibodies	B-protein
against	O
the	O
T	B-protein
cell	I-protein
receptor-CD3	I-protein
complex	I-protein
and	O
to	O
CD28	B-protein
.	O

The	O
activation	O
of	O
JNK	B-protein
by	O
classical	O
T	O
cell	O
stimuli	O
was	O
transient	O
,	O
whereas	O
that	O
mediated	O
by	O
PDTC	O
and	O
butylated	O
hydroxyanisole	O
(	O
but	O
not	O
N-acetylcysteine	O
)	O
was	O
sustained	O
.	O

The	O
kinetics	O
of	O
JNK	B-protein
activation	O
correlated	O
with	O
the	O
expression	O
of	O
c-jun	B-DNA
which	O
was	O
transient	O
after	O
stimulation	O
with	O
PMA	O
plus	O
ionophore	O
and	O
prolonged	O
in	O
response	O
to	O
PDTC	O
,	O
which	O
also	O
transiently	O
induced	O
c-fos	B-DNA
.	O

In	O
addition	O
,	O
JNK	B-protein
activation	O
by	O
PMA	O
plus	O
ionophore	O
was	O
sensitive	O
to	O
inhibitors	O
of	O
signaling	O
pathways	O
involving	O
Ca2+	O
,	O
protein	B-protein
kinase	I-protein
C	I-protein
,	O
and	O
tyrosine	O
phosphorylation	O
,	O
which	O
failed	O
to	O
inhibit	O
the	O
activation	O
mediated	O
by	O
PDTC	O
.	O

Transfection	O
of	O
trans-dominant	B-DNA
negative	I-DNA
expression	I-DNA
vectors	I-DNA
of	O
ras	B-DNA
and	O
raf	B-DNA
,	O
together	O
with	O
AP-1-dependent	B-DNA
reporter	I-DNA
constructs	I-DNA
,	O
as	O
well	O
as	O
Western	O
blot	O
analysis	O
using	O
anti-ERK	B-protein
(	I-protein
extracellular	I-protein
signal-regulated	I-protein
kinase	I-protein
)	I-protein
antibodies	I-protein
,	O
indicated	O
that	O
the	O
Ras/Raf/ERK	O
pathway	O
did	O
not	O
appear	O
to	O
mediate	O
the	O
effect	O
of	O
the	O
antioxidant	O
.	O

However	O
,	O
the	O
combined	O
treatment	O
with	O
PDTC	O
and	O
PMA	O
,	O
two	O
agents	O
that	O
synergize	O
on	O
AP-1	B-protein
activation	O
,	O
resulted	O
in	O
the	O
persistent	O
phosphorylation	O
of	O
ERK-2	B-protein
.	O

In	O
conclusion	O
,	O
our	O
results	O
identify	O
JNK	B-protein
as	O
a	O
target	O
of	O
antioxidant	O
agents	O
which	O
can	O
be	O
regulated	O
differentially	O
under	O
oxidant	O
and	O
antioxidant	O
conditions	O
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

271	NULL
,	NULL
No	NULL
.	NULL

42	NULL
,	NULL
Issue	NULL
of	NULL
October	NULL
18	NULL
,	NULL
pp	NULL
.	NULL

26335-26340	NULL
,	NULL
1996	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
JNK	NULL
(	NULL
c-Jun	NULL
Kinase	NULL
)	NULL
Is	NULL
a	NULL
Target	NULL
for	NULL
Antioxidants	NULL
in	NULL
T	NULL
Lymphocytes*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
May	NULL
21	NULL
,	NULL
1996	NULL
)	NULL
Pablo	NULL
Gomez	NULL
del	NULL
Arco	NULL
#	NULL
g§	NULL
,	NULL
Sara	NULL
Martinez-Martinez	NULL
}	NULL
#	NULL
1	NULL
,	NULL
Victor	NULL
Calvo	NULL
]	NULL
,	NULL
Angel	NULL
Luis	NULL
Armesilla	NULL
$	NULL
#	NULL
**	NULL
,	NULL
and	NULL
Juan	NULL
Miguel	NULL
Redondot	NULL
#	NULL
#	NULL
From	NULL
{	NULL
Centro	NULL
de	NULL
Biologia	NULL
Molecular	NULL
y	NULL
Servicio	NULL
de	NULL
Inmunologia	NULL
,	NULL
Hospital	NULL
de	NULL
la	NULL
Princesa	NULL
,	NULL
Consejo	NULL
Superior	NULL
de	NULL
Investigaciones	NULL
Cientificas	NULL
(	NULL
CSIC	NULL
)	NULL
-Universidad	NULL
Autonoma	NULL
de	NULL
Madrid	NULL
,	NULL
Cantoblanco	NULL
,	NULL
Madrid	NULL
28006	NULL
,	NULL
Spain	NULL
;	NULL
and	NULL
Centro	NULL
de	NULL
Investigaciones	NULL
Biomédicas	NULL
,	NULL
CSIC-UAM	NULL
,	NULL
Madrid	NULL
28049	NULL
,	NULL
Spain	NULL
AP-1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
behave	NULL
as	NULL
a	NULL
redox-sensitive	NULL
transcription	NULL
factor	NULL
that	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
both	NULL
oxidant	NULL
and	NULL
antioxidant	NULL
stimuli	NULL
.	NULL

However	NULL
,	NULL
the	NULL
mechanisms	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
AP-1	NULL
by	NULL
antioxidants	NULL
are	NULL
largely	NULL
unknown	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
show	NULL
that	NULL
the	NULL
structurally	NULL
unrelated	NULL
antioxidant	NULL
agents	NULL
pyrrolidine	NULL
dithiocarbamate	NULL
(	NULL
PDTC	NULL
)	NULL
,	NULL
butylated	NULL
hydroxyanisole	NULL
,	NULL
and	NULL
N-acetylcysteine	NULL
activated	NULL
JNK	NULL
(	NULL
c-Jun	NULL
NH	NULL
,	NULL
-terminal	NULL
kinase	NULL
)	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
activation	NULL
differed	NULL
substantially	NULL
from	NULL
that	NULL
mediated	NULL
by	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
and	NULL
Ca	NULL
``	NULL
*	NULL
ionophore	NULL
or	NULL
produced	NULL
by	NULL
costimulation	NULL
with	NULL
antibodies	NULL
against	NULL
the	NULL
T	NULL
cell	NULL
receptor-CD3	NULL
complex	NULL
and	NULL
to	NULL
CD28	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
JNK	NULL
by	NULL
classical	NULL
T	NULL
cell	NULL
stimuli	NULL
was	NULL
transient	NULL
,	NULL
whereas	NULL
that	NULL
mediated	NULL
by	NULL
PDTC	NULL
and	NULL
butylated	NULL
hydroxyanisole	NULL
(	NULL
but	NULL
not	NULL
N-acetylcysteine	NULL
)	NULL
was	NULL
sustained	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
JNK	NULL
activation	NULL
correlated	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
c-jun	NULL
which	NULL
was	NULL
transient	NULL
after	NULL
stimulation	NULL
with	NULL
PMA	NULL
plus	NULL
ionophore	NULL
and	NULL
prolonged	NULL
in	NULL
response	NULL
to	NULL
PDTC	NULL
,	NULL
which	NULL
also	NULL
transiently	NULL
induced	NULL
c-fos	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
JNK	NULL
activation	NULL
by	NULL
PMA	NULL
plus	NULL
ionophore	NULL
was	NULL
sensitive	NULL
to	NULL
inhibitors	NULL
of	NULL
signaling	NULL
pathways	NULL
involving	NULL
Ca*	NULL
``	NULL
*	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
,	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
which	NULL
failed	NULL
to	NULL
inhibit	NULL
the	NULL
activation	NULL
mediated	NULL
by	NULL
PDTC	NULL
.	NULL

Transfection	NULL
of	NULL
frans-dominant	NULL
negative	NULL
expression	NULL
vectors	NULL
of	NULL
ras	NULL
and	NULL
raf	NULL
,	NULL
together	NULL
with	NULL
AP-l-dependent	NULL
reporter	NULL
constructs	NULL
,	NULL
as	NULL
well	NULL
as	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
anti-ERK	NULL
(	NULL
extracel-lular	NULL
signal-regulated	NULL
kinase	NULL
)	NULL
antibodies	NULL
,	NULL
indicated	NULL
that	NULL
the	NULL
Ras/Raf/ERK	NULL
pathway	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
mediate	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
antioxidant	NULL
.	NULL

However	NULL
,	NULL
the	NULL
combined	NULL
treatment	NULL
with	NULL
PDTC	NULL
and	NULL
PMA	NULL
,	NULL
two	NULL
agents	NULL
that	NULL
synergize	NULL
on	NULL
AP-1	NULL
activation	NULL
,	NULL
resulted	NULL
in	NULL
the	NULL
persistent	NULL
phosphorylation	NULL
of	NULL
ERK-2	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
our	NULL
results	NULL
identify	NULL
JNK	NULL
as	NULL
a	NULL
target	NULL
of	NULL
antioxidant	NULL
agents	NULL
which	NULL
can	NULL
be	NULL
regulated	NULL
differentially	NULL
under	NULL
oxidant	NULL
and	NULL
antioxidant	NULL
conditions	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
AP-1	NULL
plays	NULL
a	NULL
central	NULL
role	NULL
by	NULL
integrating	NULL
the	NULL
signals	NULL
elicited	NULL
by	NULL
a	NULL
large	NULL
number	NULL
of	NULL
extracellular	NULL
*This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
Ministerio	NULL
de	NULL
Educacion	NULL
y	NULL
Ciencia	NULL
of	NULL
Spain	NULL
Grant	NULL
CICYT	NULL
SAF	NULL
94.0817	NULL
and	NULL
Comunidad	NULL
Auténoma	NULL
de	NULL
Madrid	NULL
Grants	NULL
AE	NULL
60/94	NULL
and	NULL
AE	NULL
281/95	NULL
(	NULL
to	NULL
J.	NULL
M.	NULL
R.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.9.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
Supported	NULL
by	NULL
a	NULL
fellowship	NULL
from	NULL
the	NULL
Comunidad	NULL
Auténoma	NULL
de	NULL
Madrid	NULL
.	NULL

4	NULL
]	NULL
Supported	NULL
by	NULL
a	NULL
fellowship	NULL
from	NULL
the	NULL
Ministerio	NULL
de	NULL
Educacién	NULL
y	NULL
Ciencia	NULL
.	NULL

**	NULL
Supported	NULL
by	NULL
Comunidad	NULL
Autonoma	NULL
de	NULL
Madrid	NULL
Grants	NULL
AE	NULL
60/94	NULL
and	NULL
AE	NULL
281/95	NULL
.	NULL

7+	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Centro	NULL
de	NULL
Biologia	NULL
Molecular	NULL
,	NULL
CSIC-UAM	NULL
,	NULL
Facultad	NULL
de	NULL
Ciencias	NULL
,	NULL
Cantoblanco	NULL
,	NULL
Madrid	NULL
28049	NULL
,	NULL
Spain	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
84-1-397-8418	NULL
;	NULL
Fax	NULL
:	NULL
34-1-309-2496.	NULL
stimuli	NULL
including	NULL
growth	NULL
factors	NULL
,	NULL
phorbol	NULL
esters	NULL
,	NULL
UV	NULL
light	NULL
,	NULL
and	NULL
cytokines	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Homodimers	NULL
of	NULL
members	NULL
of	NULL
the	NULL
Jun	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
and	NULL
heterodimers	NULL
formed	NULL
with	NULL
these	NULL
members	NULL
and	NULL
those	NULL
of	NULL
the	NULL
Fos	NULL
family	NULL
comprise	NULL
the	NULL
AP-1	NULL
transcription	NULL
factor	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
TRE*	NULL
site	NULL
to	NULL
regulate	NULL
gene	NULL
transcription	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

The	NULL
capacity	NULL
of	NULL
AP-1	NULL
to	NULL
respond	NULL
to	NULL
a	NULL
wide	NULL
array	NULL
of	NULL
extracellular	NULL
signals	NULL
is	NULL
largely	NULL
mediated	NULL
by	NULL
the	NULL
transcription	NULL
factors	NULL
that	NULL
regulate	NULL
the	NULL
c-fos	NULL
and	NULL
c-jun	NULL
promoters	NULL
whose	NULL
binding	NULL
and	NULL
activity	NULL
are	NULL
in	NULL
turn	NULL
regulated	NULL
through	NULL
different	NULL
signaling	NULL
pathways	NULL
(	NULL
2-4	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
major	NULL
regulatory	NULL
element	NULL
within	NULL
the	NULL
c-fos	NULL
promoter	NULL
,	NULL
the	NULL
serum	NULL
response	NULL
element	NULL
(	NULL
SRE	NULL
)	NULL
,	NULL
is	NULL
recognized	NULL
by	NULL
a	NULL
complex	NULL
that	NULL
contains	NULL
the	NULL
ternary	NULL
complex	NULL
factor	NULL
(	NULL
TCF	NULL
)	NULL
YElk-1	NULL
and	NULL
the	NULL
serum	NULL
response	NULL
factor	NULL
(	NULL
3	NULL
)	NULL
.	NULL

TCF/Elk-1	NULL
is	NULL
phosphorylated	NULL
rapidly	NULL
in	NULL
response	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
stimuli	NULL
by	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
ERK-1	NULL
and	NULL
ERK-2	NULL
,	NULL
which	NULL
are	NULL
activated	NULL
by	NULL
the	NULL
Ras/Raf/ERK	NULL
kinase	NULL
cascade	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

The	NULL
sequential	NULL
activation	NULL
and	NULL
phosphorylation	NULL
of	NULL
ERK	NULL
and	NULL
TCF/EIk-1	NULL
facilitate	NULL
the	NULL
SRE	NULL
ternary	NULL
complex	NULL
formation	NULL
and	NULL
the	NULL
subsequent	NULL
transcriptional	NULL
induction	NULL
of	NULL
c-fos	NULL
(	NULL
6-8	NULL
)	NULL
.	NULL

Transcription	NULL
of	NULL
c-jun	NULL
is	NULL
activated	NULL
by	NULL
binding	NULL
of	NULL
preformed	NULL
homodimers	NULL
of	NULL
c-Jun	NULL
or	NULL
heterodimers	NULL
of	NULL
c-Jun	NULL
and	NULL
ATF-2	NULL
to	NULL
the	NULL
TRE	NULL
of	NULL
the	NULL
c-jun	NULL
promoter	NULL
.	NULL

Both	NULL
transcription	NULL
factors	NULL
c-jun	NULL
and	NULL
ATF-2	NULL
are	NULL
phosphorylated	NULL
by	NULL
another	NULL
group	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
denominated	NULL
JNKs/SAPKs	NULL
(	NULL
c-Jun	NULL
NH	NULL
,	NULL
-terminal	NULL
kinases/stress-activated	NULL
protein	NULL
kinases	NULL
)	NULL
(	NULL
9-11	NULL
)	NULL
,	NULL
which	NULL
are	NULL
activated	NULL
early	NULL
by	NULL
upstream	NULL
signal	NULL
transduction	NULL
pathways	NULL
involving	NULL
kinase	NULL
cascades	NULL
different	NULL
from	NULL
those	NULL
regulating	NULL
the	NULL
ERKs	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

Although	NULL
several	NULL
growth	NULL
factors	NULL
stimulate	NULL
the	NULL
ERK	NULL
pathway	NULL
and	NULL
induce	NULL
c-fos	NULL
involving	NULL
the	NULL
phosphorylation	NULL
of	NULL
TCF/Elk-1	NULL
,	NULL
exposure	NULL
of	NULL
cells	NULL
to	NULL
stress	NULL
induced	NULL
by	NULL
UV	NULL
radiation	NULL
(	NULL
14	NULL
)	NULL
or	NULL
by	NULL
protein	NULL
synthesis	NULL
inhibitors	NULL
(	NULL
15	NULL
)	NULL
,	NULL
which	NULL
occurred	NULL
with	NULL
c-fos	NULL
gene	NULL
expression	NULL
,	NULL
did	NULL
not	NULL
involve	NULL
activation	NULL
of	NULL
the	NULL
ERK	NULL
pathway	NULL
.	NULL

Recently	NULL
,	NULL
studies	NULL
on	NULL
the	NULL
mechanisms	NULL
involved	NULL
in	NULL
TCF/	NULL
Elk-1	NULL
phosphorylation	NULL
indicated	NULL
that	NULL
this	NULL
factor	NULL
is	NULL
a	NULL
point	NULL
of	NULL
convergence	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinases/ERKs	NULL
and	NULL
JNK/SAPK	NULL
signaling	NULL
pathways	NULL
,	NULL
since	NULL
JNKs/SAPKs	NULL
can	NULL
also	NULL
phosphorylate	NULL
TCF/EIk-1	NULL
in	NULL
response	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
stimuli	NULL
(	NULL
13	NULL
,	NULL
16-19	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
JNK	NULL
activation	NULL
itself	NULL
could	NULL
account	NULL
for	NULL
AP-1	NULL
activation	NULL
,	NULL
since	NULL
TCF/EIk-1	NULL
,	NULL
c-Jun	NULL
,	NULL
and	NULL
ATF-2	NULL
,	NULL
factors	NULL
critically	NULL
involved	NULL
in	NULL
the	NULL
transcription	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
,	NULL
are	NULL
targets	NULL
that	NULL
can	NULL
be	NULL
phosphorylated	NULL
by	NULL
this	NULL
kinase	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
TRE	NULL
,	NULL
TPA	NULL
(	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
)	NULL
response	NULL
element	NULL
;	NULL
SRE	NULL
,	NULL
serum	NULL
response	NULL
element	NULL
;	NULL
TCF	NULL
,	NULL
ternary	NULL
complex	NULL
factor	NULL
;	NULL
ERK	NULL
,	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
;	NULL
JNK	NULL
,	NULL
c-Jun	NULL
NH-terminal	NULL
kinase	NULL
;	NULL
SAPK	NULL
,	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
;	NULL
NFkB	NULL
,	NULL
nuclear	NULL
factor	NULL
kB	NULL
;	NULL
PDTC	NULL
,	NULL
pyrrolidine	NULL
dithiocarbamate	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
18-acetate	NULL
;	NULL
BHA	NULL
,	NULL
butylated	NULL
hydroxyanisole	NULL
;	NULL
kb	NULL
,	NULL
kilobase	NULL
;	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
TBS-T	NULL
,	NULL
Tris-buffered	NULL
saline-T'ween	NULL
;	NULL
GST	NULL
,	NULL
glutathione	NULL
S-transferase	NULL
.	NULL

26335	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
26336	NULL
The	NULL
activity	NULL
of	NULL
the	NULL
AP-1	NULL
and	NULL
NFxB	NULL
transcription	NULL
factors	NULL
is	NULL
regulated	NULL
differentially	NULL
in	NULL
T	NULL
lymphocytes	NULL
in	NULL
response	NULL
to	NULL
changes	NULL
in	NULL
the	NULL
cell	NULL
redox	NULL
state	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
use	NULL
of	NULL
antioxidants	NULL
with	NULL
radical	NULL
scavenger	NULL
properties	NULL
has	NULL
evidenced	NULL
a	NULL
role	NULL
for	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
,	NULL
generated	NULL
under	NULL
prooxidant	NULL
con-ditions	NULL
,	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
NFB	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
NFkB	NULL
in	NULL
response	NULL
to	NULL
oxidative	NULL
stress	NULL
is	NULL
inhibited	NULL
by	NULL
several	NULL
structurally	NULL
unrelated	NULL
antioxidants	NULL
including	NULL
dithiocarba-mates	NULL
(	NULL
21-24	NULL
)	NULL
,	NULL
the	NULL
antioxidant	NULL
enzyme	NULL
thioredoxin	NULL
(	NULL
23-25	NULL
)	NULL
,	NULL
and	NULL
the	NULL
glutathione	NULL
precursor	NULL
N-acetylcysteine	NULL
(	NULL
21	NULL
,	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

AP-1	NULL
is	NULL
also	NULL
activated	NULL
by	NULL
a	NULL
number	NULL
of	NULL
stimuli	NULL
that	NULL
generate	NULL
oxidative	NULL
stress	NULL
(	NULL
23	NULL
,	NULL
28-31	NULL
)	NULL
.	NULL

However	NULL
,	NULL
these	NULL
antioxidants	NULL
that	NULL
block	NULL
NFB	NULL
activation	NULL
efficiently	NULL
paradoxically	NULL
stimulate	NULL
the	NULL
DNA	NULL
binding	NULL
and	NULL
transcriptional	NULL
activities	NULL
of	NULL
AP-1	NULL
involving	NULL
induction	NULL
of	NULL
the	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNAs	NULL
(	NULL
23	NULL
,	NULL
24	NULL
,	NULL
32	NULL
)	NULL
and	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
SRE	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
signals	NULL
triggered	NULL
under	NULL
both	NULL
prooxidant	NULL
and	NULL
antioxidant	NULL
conditions	NULL
can	NULL
lead	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
AP-1	NULL
.	NULL

To	NULL
understand	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
antioxidants	NULL
activate	NULL
AP-1	NULL
,	NULL
we	NULL
analyzed	NULL
their	NULL
effects	NULL
on	NULL
different	NULL
signal	NULL
transduction	NULL
pathways	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

We	NULL
found	NULL
that	NULL
different	NULL
antioxidant	NULL
agents	NULL
stimulate	NULL
JNK	NULL
activity	NULL
.	NULL

Further-more	NULL
,	NULL
we	NULL
studied	NULL
the	NULL
antioxidant-induced	NULL
signaling	NULL
in	NULL
T	NULL
lymphocytes	NULL
using	NULL
pyrrolidine	NULL
dithiocarbamate	NULL
(	NULL
PDTC	NULL
)	NULL
,	NULL
a	NULL
potent	NULL
antioxidant	NULL
agent	NULL
that	NULL
activates	NULL
AP-1	NULL
.	NULL

Our	NULL
results	NULL
are	NULL
discussed	NULL
in	NULL
the	NULL
context	NULL
of	NULL
recent	NULL
works	NULL
that	NULL
implicate	NULL
JNK	NULL
as	NULL
a	NULL
mediator	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
both	NULL
c-fos	NULL
and	NULL
c-jun	NULL
transcriptional	NULL
expression	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Cell	NULL
Culture	NULL
,	NULL
Reagents	NULL
,	NULL
and	NULL
Monoclonal	NULL
Antibodies-The	NULL
human	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
was	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
with	NULL
GLUTAMAX-I	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

Phorbol	NULL
12-myristate	NULL
1l3-acetate	NULL
(	NULL
PMA	NULL
)	NULL
,	NULL
PDTC	NULL
,	NULL
butylated	NULL
hydroxyanisole	NULL
(	NULL
BHA	NULL
)	NULL
,	NULL
N-acetylcysteine	NULL
,	NULL
and	NULL
the	NULL
calcium	NULL
ionophore	NULL
A283187	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
.	NULL

Cyclosporin	NULL
A	NULL
was	NULL
from	NULL
Sandoz	NULL
.	NULL

BisindolyImaleim-ide	NULL
and	NULL
herbimycin	NULL
A	NULL
were	NULL
from	NULL
Calbiochem	NULL
.	NULL

The	NULL
purified	NULL
activating	NULL
anti-CD28.2	NULL
monoclonal	NULL
antibody	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
D.	NULL
Olive	NULL
,	NULL
and	NULL
the	NULL
anti-CD3	NULL
SPV-T3	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
83	NULL
)	NULL
.	NULL

RNA	NULL
Analysis-Jurkat	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
PDTC	NULL
,	NULL
PMA	NULL
plus	NULL
ionophore	NULL
,	NULL
or	NULL
pretreated	NULL
with	NULL
PDTC	NULL
and	NULL
then	NULL
exposed	NULL
to	NULL
PMA	NULL
plus	NULL
ionophore	NULL
.	NULL

After	NULL
various	NULL
time	NULL
points	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
using	NULL
the	NULL
Ultraspec	NULL
system	NULL
(	NULL
Biotox	NULL
Laboratories	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

For	NULL
dot-blot	NULL
analysis	NULL
,	NULL
RNA	NULL
from	NULL
each	NULL
sample	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
was	NULL
denatured	NULL
and	NULL
blotted	NULL
onto	NULL
nitrocellulose	NULL
membranes	NULL
in	NULL
a	NULL
Bio-Dot	NULL
SF	NULL
mi-crofiltration	NULL
apparatus	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

For	NULL
Northern	NULL
blot	NULL
analysis	NULL
denatured	NULL
RNA	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
was	NULL
electrophoresed	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
and	NULL
blotted	NULL
onto	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
.	NULL

After	NULL
UV	NULL
cross-linking	NULL
,	NULL
the	NULL
filters	NULL
were	NULL
hybridized	NULL
with	NULL
the	NULL
corresponding	NULL
specific	NULL
probes	NULL
:	NULL
a	NULL
0.8-kb	NULL
Bg/II-Ncol	NULL
fragment	NULL
of	NULL
c-fos	NULL
cDNA	NULL
,	NULL
a	NULL
0.8-kb	NULL
HindIII-Pstl	NULL
fragment	NULL
of	NULL
c-jun	NULL
cDNA	NULL
,	NULL
a	NULL
1.8-kb	NULL
EcoRI	NULL
fragment	NULL
of	NULL
human	NULL
PAC-1	NULL
eDNA	NULL
(	NULL
84	NULL
)	NULL
,	NULL
and	NULL
a	NULL
0.6-kb	NULL
HindII-BamHI	NULL
fragment	NULL
of	NULL
B-actin	NULL
cDNA	NULL
.	NULL

Plasmid	NULL
Constructs-The	NULL
plasmids	NULL
used	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
activated	NULL
v-Ha-ras	NULL
,	NULL
dominant	NULL
negative	NULL
ras	NULL
,	NULL
and	NULL
dominant	NULL
negative	NULL
raf	NULL
were	NULL
provided	NULL
by	NULL
Dr.	NULL
D.	NULL
Cantrell	NULL
.	NULL

These	NULL
plasmids	NULL
were	NULL
generated	NULL
by	NULL
inserting	NULL
a	NULL
0.7-kb	NULL
BamHI	NULL
fragment	NULL
of	NULL
v-Ha-ras	NULL
(	NULL
activated	NULL
ras	NULL
)	NULL
,	NULL
a	NULL
4.4-kb	NULL
Xhol-BamHI	NULL
fragment	NULL
of	NULL
c-Ha-ras	NULL
N17	NULL
(	NULL
ras	NULL
dominant	NULL
negative	NULL
)	NULL
,	NULL
and	NULL
a	NULL
0.8-kb	NULL
polymerase	NULL
chain	NULL
reaction	NULL
fragment	NULL
containing	NULL
a	NULL
carboxyl-ter-minal	NULL
truncated	NULL
form	NULL
of	NULL
raf	NULL
(	NULL
dominant	NULL
negative	NULL
)	NULL
into	NULL
the	NULL
pEFBOS	NULL
expression	NULL
vector	NULL
(	NULL
85	NULL
)	NULL
.	NULL

The	NULL
IL-2Luc	NULL
reporter	NULL
construct	NULL
containing	NULL
the	NULL
-826	NULL
to	NULL
+45	NULL
human	NULL
IL-2	NULL
promoter/enhancer	NULL
region	NULL
fused	NULL
to	NULL
the	NULL
luciferase	NULL
gene	NULL
(	NULL
86	NULL
)	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
G.	NULL
Crabtree	NULL
.	NULL

The	NULL
78colLue	NULL
and	NULL
60colLue	NULL
plasmids	NULL
including	NULL
the	NULL
AP-1-responsive	NULL
(	NULL
-73/+683	NULL
base	NULL
pairs	NULL
)	NULL
and	NULL
the	NULL
AP-1-unresponsive	NULL
(	NULL
-60/+63	NULL
base	NULL
pairs	NULL
)	NULL
regions	NULL
of	NULL
the	NULL
human	NULL
collagenase	NULL
promoter	NULL
fused	NULL
to	NULL
the	NULL
luciferase	NULL
gene	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
87	NULL
)	NULL
and	NULL
were	NULL
provided	NULL
by	NULL
Dr.	NULL
M.	NULL
Karin	NULL
.	NULL

Nuclear	NULL
Extracts	NULL
and	NULL
Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
(	NULL
EMSA	NULL
)	NULL
-Small	NULL
scale	NULL
nuclear	NULL
extracts	NULL
were	NULL
obtained	NULL
from	NULL
10	NULL
``	NULL
Jurkat	NULL
cells	NULL
following	NULL
a	NULL
procedure	NULL
described	NULL
previously	NULL
(	NULL
88	NULL
)	NULL
but	NULL
included	NULL
in	NULL
the	NULL
extracting	NULL
buffers	NULL
10	NULL
mM	NULL
sodium	NULL
orthomolybdate	NULL
,	NULL
1	NULL
pg/ml	NULL
aprotinin	NULL
,	NULL
1	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
1	NULL
ug/ml	NULL
pepstatin	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
.	NULL

EMSAs	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
82	NULL
)	NULL
except	NULL
for	NULL
the	NULL
bind	NULL
Antioxidants	NULL
Activate	NULL
JNK	NULL
ing	NULL
reactions	NULL
that	NULL
were	NULL
performed	NULL
using	NULL
5	NULL
ug	NULL
of	NULL
nuclear	NULL
proteins	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
DNA	NULL
carrier	NULL
.	NULL

The	NULL
double-stranded	NULL
oligonucleotide	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
EMSAs	NULL
,	NULL
5-GCCCCCTCTGACTCATGCTGACA-3	NULL
'	NULL
,	NULL
included	NULL
the	NULL
-68	NULL
to	NULL
-46	NULL
base	NULL
pairs	NULL
of	NULL
the	NULL
CD11Ic	NULL
promoter	NULL
(	NULL
82	NULL
)	NULL
containing	NULL
an	NULL
AP-1	NULL
consensus	NULL
site	NULL
.	NULL

Transfection	NULL
Experiments-Jurkat	NULL
cells	NULL
(	NULL
10	NULL
``	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
Lipofectin	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
manufac-turer	NULL
.	NULL

Briefly	NULL
,	NULL
exponentially	NULL
growing	NULL
cells	NULL
(	NULL
8-7	NULL
X	NULL
10°/ml	NULL
)	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
resuspended	NULL
in	NULL
Opti-MEM	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
12	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
with	NULL
a	NULL
mixture	NULL
of	NULL
5	NULL
ug/ml	NULL
plasmid	NULL
DNA	NULL
and	NULL
10	NULL
ug/ml	NULL
Lipofectin	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
Opti-MEM	NULL
.	NULL

Then	NULL
,	NULL
cells	NULL
were	NULL
diluted	NULL
with	NULL
14	NULL
ml	NULL
of	NULL
complete	NULL
medium	NULL
(	NULL
RPMI	NULL
and	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
)	NULL
and	NULL
incubated	NULL
for	NULL
36	NULL
h.	NULL
Cells	NULL
were	NULL
then	NULL
treated	NULL
with	NULL
different	NULL
stimuli	NULL
for	NULL
12	NULL
additional	NULL
h	NULL
,	NULL
collected	NULL
by	NULL
centrifugation	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
determined	NULL
following	NULL
instructions	NULL
described	NULL
in	NULL
a	NULL
luciferase	NULL
assay	NULL
kit	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

In	NULL
cotransfection	NULL
experiments	NULL
with	NULL
expression	NULL
vectors	NULL
,	NULL
the	NULL
same	NULL
protocol	NULL
was	NULL
followed	NULL
,	NULL
but	NULL
the	NULL
reporter	NULL
and	NULL
expression	NULL
plasmids	NULL
were	NULL
added	NULL
at	NULL
concentrations	NULL
of	NULL
5	NULL
and	NULL
10	NULL
pg/ml	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
the	NULL
Lipofectin	NULL
to	NULL
10	NULL
ug/ml	NULL
.	NULL

Western	NULL
Blot	NULL
Analysis-Western	NULL
blot	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
89	NULL
)	NULL
with	NULL
the	NULL
following	NULL
modifications	NULL
.	NULL

Cells	NULL
(	NULL
10°	NULL
)	NULL
were	NULL
washed	NULL
and	NULL
lysed	NULL
in	NULL
200	NULL
ul	NULL
of	NULL
buffer	NULL
A	NULL
(	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
50	NULL
mM	NULL
B-glycerophosphate	NULL
,	NULL
0.1	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
0.5	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
2	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
2	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
2	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
3	NULL
nM	NULL
okadaic	NULL
acid	NULL
)	NULL
.	NULL

After	NULL
vortex	NULL
,	NULL
cells	NULL
were	NULL
kept	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
and	NULL
microcentrifuged	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Supernatants	NULL
were	NULL
col-lected	NULL
,	NULL
mixed	NULL
with	NULL
loading	NULL
buffer	NULL
,	NULL
and	NULL
separated	NULL
by	NULL
8	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Gels	NULL
were	NULL
transferred	NULL
to	NULL
Immobilon-P	NULL
membranes	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
blocking	NULL
solution	NULL
(	NULL
5	NULL
%	NULL
w/v	NULL
skim	NULL
milk	NULL
TBS-T	NULL
(	NULL
TBS	NULL
,	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
)	NULL
for	NULL
60	NULL
min	NULL
at	NULL
45	NULL
°C	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
TBS-T	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
anti-ERK	NULL
1	NULL
,	NULL
2	NULL
(	NULL
Zymed	NULL
,	NULL
San	NULL
Francisco	NULL
)	NULL
0.1	NULL
%	NULL
v/v	NULL
in	NULL
TBS-T	NULL
,	NULL
5	NULL
%	NULL
w/v	NULL
skim	NULL
milk	NULL
.	NULL

Then	NULL
,	NULL
membranes	NULL
were	NULL
washed	NULL
six	NULL
times	NULL
for	NULL
5	NULL
min	NULL
each	NULL
in	NULL
0.5	NULL
%	NULL
w/v	NULL
skim	NULL
milk	NULL
in	NULL
TBS-T	NULL
,	NULL
and	NULL
peroxi-dase-labeled	NULL
goat	NULL
anti-mouse	NULL
IgG	NULL
(	NULL
ICN	NULL
)	NULL
(	NULL
0.1	NULL
%	NULL
v/v	NULL
in	NULL
TBS-T	NULL
)	NULL
was	NULL
incubated	NULL
for	NULL
60	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
three	NULL
washes	NULL
with	NULL
TBS-T	NULL
and	NULL
one	NULL
with	NULL
TBS	NULL
,	NULL
membrane-bound	NULL
antibody	NULL
was	NULL
visualized	NULL
by	NULL
ECL	NULL
detection	NULL
reagent	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
.	NULL

In-gel	NULL
Kinase	NULL
Assays-In-gel	NULL
kinase	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
40	NULL
)	NULL
with	NULL
some	NULL
modifications	NULL
.	NULL

Lysates	NULL
from	NULL
10°	NULL
cells	NULL
were	NULL
diluted	NULL
in	NULL
Laemmli	NULL
sample	NULL
buffer	NULL
and	NULL
separated	NULL
by	NULL
electrophoresis	NULL
in	NULL
a	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
polymerized	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GST-c-Jun	NULL
,	NULL
_	NULL
,	NULL
,	NULL
fusion	NULL
protein	NULL
.	NULL

GST-c-Jun	NULL
protein	NULL
was	NULL
isolated	NULL
from	NULL
250	NULL
ml	NULL
of	NULL
bacterial	NULL
cells	NULL
expressing	NULL
pGEX-c-Jun	NULL
,	NULL
;	NULL
,	NULL
,	NULL
plasmid	NULL
(	NULL
provided	NULL
by	NULL
Dr.	NULL
R.	NULL
Davis	NULL
)	NULL
using	NULL
GSH-Shepharose	NULL
4B	NULL
beads	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
Inc.	NULL
)	NULL
.	NULL

After	NULL
electrophoresis	NULL
,	NULL
the	NULL
gel	NULL
was	NULL
washed	NULL
twice	NULL
for	NULL
15	NULL
min	NULL
in	NULL
100	NULL
ml	NULL
of	NULL
20	NULL
%	NULL
v/v	NULL
2-propanol	NULL
,	NULL
50	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
and	NULL
then	NULL
equilibrated	NULL
with	NULL
two	NULL
15-min	NULL
changes	NULL
of	NULL
100	NULL
ml	NULL
of	NULL
buffer	NULL
A	NULL
(	NULL
50	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
5	NULL
mM	NULL
B-mercaptoethanol	NULL
)	NULL
.	NULL

Proteins	NULL
were	NULL
denatured	NULL
by	NULL
incubating	NULL
the	NULL
gel	NULL
twice	NULL
for	NULL
15	NULL
min	NULL
in	NULL
100	NULL
ml	NULL
of	NULL
6	NULL
M	NULL
urea	NULL
in	NULL
buffer	NULL
A	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

This	NULL
was	NULL
followed	NULL
by	NULL
four	NULL
sequential	NULL
renaturation	NULL
steps	NULL
(	NULL
15	NULL
min	NULL
each	NULL
)	NULL
by	NULL
discarding	NULL
half	NULL
of	NULL
the	NULL
volume	NULL
(	NULL
50	NULL
ml	NULL
)	NULL
and	NULL
replacing	NULL
it	NULL
with	NULL
ice-cold	NULL
renaturation	NULL
buffer	NULL
(	NULL
0.05	NULL
%	NULL
v/v	NULL
Tween	NULL
20	NULL
in	NULL
buffer	NULL
A	NULL
)	NULL
at	NULL
4°C	NULL
.	NULL

After	NULL
washing	NULL
three	NULL
or	NULL
four	NULL
times	NULL
with	NULL
150	NULL
ml	NULL
of	NULL
renaturation	NULL
buffer	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
the	NULL
gel	NULL
was	NULL
immersed	NULL
in	NULL
25	NULL
ml	NULL
of	NULL
kinase	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
20	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
5	NULL
mM	NULL
B-glycerophosphate	NULL
,	NULL
0.1	NULL
mM	NULL
sodium	NULL
vanadate	NULL
,	NULL
2	NULL
mM	NULL
dithiothreitol	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
and	NULL
incubated	NULL
further	NULL
in	NULL
15	NULL
ml	NULL
of	NULL
kinase	NULL
buffer	NULL
containing	NULL
20	NULL
uM	NULL
ATP	NULL
and	NULL
100	NULL
uCi	NULL
of	NULL
[	NULL
y-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
ATP	NULL
at	NULL
30	NULL
°C	NULL
for	NULL
1-2	NULL
h.	NULL
Finally	NULL
,	NULL
the	NULL
gel	NULL
was	NULL
washed	NULL
four	NULL
times	NULL
with	NULL
150-200	NULL
ml	NULL
of	NULL
5	NULL
%	NULL
viv	NULL
trichloroacetic	NULL
acid	NULL
and	NULL
1	NULL
%	NULL
v/v	NULL
sodium	NULL
pyrophosphate	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
exposed	NULL
for	NULL
1-2	NULL
days	NULL
.	NULL

RESULTS	NULL
Changes	NULL
in	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
Levels	NULL
in	NULL
Jurkat	NULL
Cells	NULL
Induced	NULL
by	NULL
PDTC-Since	NULL
different	NULL
antioxidant	NULL
agents	NULL
,	NULL
including	NULL
PDTC	NULL
,	NULL
activate	NULL
AP-1	NULL
,	NULL
we	NULL
analyzed	NULL
further	NULL
the	NULL
effect	NULL
of	NULL
PDTC	NULL
on	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
steady	NULL
state	NULL
.	NULL

Kinetic	NULL
experiments	NULL
using	NULL
total	NULL
RNA	NULL
from	NULL
Jurkat	NULL
cells	NULL
treated	NULL
with	NULL
PDTC	NULL
and	NULL
from	NULL
cells	NULL
treated	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
the	NULL
phorbol	NULL
ester	NULL
PMA	NULL
and	NULL
the	NULL
Ca**	NULL
ionophore	NULL
A23187	NULL
,	NULL
either	NULL
pretreated	NULL
or	NULL
not	NULL
with	NULL
PDTC	NULL
,	NULL
were	NULL
carried	NULL
out	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Incubation	NULL
with	NULL
PMA	NULL
plus	NULL
A23187	NULL
resulted	NULL
in	NULL
transient	NULL
induction	NULL
of	NULL
both	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
levels	NULL
,	NULL
having	NULL
maximal	NULL
values	NULL
at	NULL
30-60	NULL
min	NULL
,	NULL
whereas	NULL
exposure	NULL
to	NULL
PDTC	NULL
caused	NULL
a	NULL
prolonged	NULL
expression	NULL
of	NULL
c-jun	NULL
mRNA	NULL
reaching	NULL
maximal	NULL
levels	NULL
between	NULL
1	NULL
and	NULL
4	NULL
h	NULL
and	NULL
remained	NULL
high	NULL
for	NULL
at	NULL
least	NULL
10	NULL
h.	NULL
PDTC	NULL
induced	NULL
a	NULL
weaker	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Antioxidants	NULL
Activate	NULL
JNK	NULL
A	NULL
-	NULL
0.25	NULL
0.5	NULL
10	NULL
40070	NULL
10	NULL
_	NULL
hours	NULL
0	NULL
o	NULL
e	NULL
»	NULL
PMA	NULL
+Io	NULL
c-fos	NULL
#	NULL
&	NULL
®	NULL
#	NULL
#	NULL
#	NULL
PDTC	NULL
©	NULL
0	NULL
@	NULL
o	NULL
a	NULL
#	NULL
PMA+lo/PDTC	NULL
-	NULL
0.25	NULL
0.5	NULL
1	NULL
4	NULL
7	NULL
10	NULL
hours	NULL
@	NULL
@	NULL
@	NULL
@	NULL
#	NULL
s	NULL
a	NULL
PrmMa+lo	NULL
c-jun	NULL
o	NULL
0	NULL
0	NULL
0	NULL
0	NULL
a	NULL
0	NULL
0	NULL
@	NULL
eo	NULL
a	NULL
ao	NULL
ruamiororc	NULL
-	NULL
0.25	NULL
0.5	NULL
1	NULL
4	NULL
7	NULL
10	NULL
hours	NULL
o	NULL
0	NULL
0	NULL
0	NULL
0	NULL
0	NULL
a	NULL
--	NULL
-B-actin	NULL
0	NULL
0	NULL
0	NULL
0	NULL
0	NULL
a	NULL
0	NULL
0	NULL
0	NULL
0	NULL
0	NULL
@	NULL
W	NULL
B	NULL
k	NULL
a	NULL
Ba	NULL
o	NULL
o	NULL
~	NULL
:	NULL
2	NULL
a	NULL
a	NULL
~s	NULL
Io	NULL
Bo	NULL
&	NULL
&	NULL
-	NULL
wos	NULL
on	NULL
AP-1	NULL
PROBE	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Effects	NULL
of	NULL
PDTC	NULL
and	NULL
PMA	NULL
plus	NULL
ionophore	NULL
on	NULL
RNA	NULL
levels	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
and	NULL
on	NULL
AP-1	NULL
binding	NULL
activity	NULL
.	NULL

Panel	NULL
A	NULL
,	NULL
dot-blot	NULL
analysis	NULL
using	NULL
total	NULL
RNA	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
treated	NULL
with	NULL
50	NULL
um	NULL
PDTC	NULL
,	NULL
20	NULL
ng/ml	NULL
PMA	NULL
plus	NULL
1	NULL
um	NULL
A23187	NULL
(	NULL
Jo	NULL
)	NULL
or	NULL
pretreated	NULL
with	NULL
50	NULL
um	NULL
PDTC	NULL
for	NULL
2	NULL
h	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
20	NULL
ng/ml	NULL
PMA	NULL
plus	NULL
1	NULL
um	NULL
A23187	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

RNA	NULL
was	NULL
hybridized	NULL
with	NULL
probes	NULL
of	NULL
c-fos	NULL
,	NULL
cgun	NULL
,	NULL
and	NULL
f-actin	NULL
.	NULL

Panel	NULL
B	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
cells	NULL
treated	NULL
with	NULL
50	NULL
uM	NULL
PDTC	NULL
,	NULL
20	NULL
ng/ml	NULL
PMA	NULL
plus	NULL
1	NULL
um	NULL
A23187	NULL
for	NULL
4	NULL
h	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
pretreated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
PDTC	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
PMA	NULL
plus	NULL
A23187	NULL
(	NULL
at	NULL
the	NULL
same	NULL
doses	NULL
as	NULL
those	NULL
used	NULL
in	NULL
separate	NULL
treatments	NULL
)	NULL
for	NULL
an	NULL
additional	NULL
4	NULL
h	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
probe	NULL
containing	NULL
the	NULL
TRE	NULL
consensus	NULL
sequence	NULL
of	NULL
the	NULL
CD11c	NULL
promoter	NULL
,	NULL
and	NULL
complexes	NULL
were	NULL
resolved	NULL
in	NULL
an	NULL
EMSA	NULL
.	NULL

expression	NULL
of	NULL
c-fos	NULL
mRNA	NULL
although	NULL
displaying	NULL
kinetics	NULL
different	NULL
from	NULL
that	NULL
exerted	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
PMA	NULL
and	NULL
ionophore	NULL
.	NULL

Strikingly	NULL
,	NULL
the	NULL
incubation	NULL
of	NULL
Jurkat	NULL
cells	NULL
with	NULL
PDTC	NULL
prior	NULL
to	NULL
stimulation	NULL
with	NULL
PMA	NULL
plus	NULL
ionophore	NULL
led	NULL
to	NULL
a	NULL
prolonged	NULL
induction	NULL
not	NULL
only	NULL
of	NULL
the	NULL
c-jun	NULL
mRNA	NULL
levels	NULL
,	NULL
but	NULL
also	NULL
of	NULL
the	NULL
c-fos	NULL
levels	NULL
,	NULL
which	NULL
were	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
higher	NULL
than	NULL
those	NULL
obtained	NULL
with	NULL
PDTC	NULL
and	NULL
PMA-ionophore	NULL
separately	NULL
.	NULL

As	NULL
shown	NULL
previously	NULL
for	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
23	NULL
,	NULL
24	NULL
,	NULL
32	NULL
)	NULL
,	NULL
EMSA	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
a	NULL
consensus	NULL
AP-1	NULL
probe	NULL
confirmed	NULL
that	NULL
PDTC	NULL
(	NULL
and	NULL
PMA-ionophore	NULL
)	NULL
induced	NULL
AP-1	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
and	NULL
TRE-dependent	NULL
transcriptional	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
these	NULL
data	NULL
indicated	NULL
that	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
PDTC	NULL
is	NULL
able	NULL
,	NULL
by	NULL
itself	NULL
,	NULL
to	NULL
induce	NULL
a	NULL
26337	NULL
A	NULL
-73collLuc	NULL
J	NULL
-73collLue	NULL
14	NULL
)	NULL
-	NULL
Wlper	NULL
Bos	NULL
13	NULL
]	NULL
-	NULL
OpEFN17	NULL
ras	NULL
Epee	NULL
sos	NULL
CpeFraf	NULL
p.N	NULL
.	NULL

(	NULL
R.L.U	NULL
)	NULL
x10~	NULL
CONTROL	NULL
PDTC	NULL
CONTROL	NULL
PDTC	NULL
O	NULL
IL-2Luce	NULL
D	NULL
IL-2Luc	NULL
**/	NULL
-	NULL
Wore	NULL
Bos	NULL
su0	NULL
CIpEFN17	NULL
ras	NULL
Elper	NULL
Bos	NULL
COUpEFraf	NULL
DN	NULL
.	NULL

sv	NULL
(	NULL
R.L.U	NULL
)	NULL
x10	NULL
*	NULL
2	NULL
*	NULL
``	NULL
(	NULL
R.L.U	NULL
)	NULL
x10	NULL
~	NULL
CONTROL	NULL
PMA/Io	NULL
CONTROL	NULL
PMA/Io	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Roles	NULL
of	NULL
Ras	NULL
and	NULL
Raf	NULL
on	NULL
the	NULL
AP-1	NULL
trans-activation	NULL
mediated	NULL
by	NULL
PDTC	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
cotransfected	NULL
by	NULL
lipofection	NULL
with	NULL
5	NULL
ug/ml	NULL
luciferase-based	NULL
plasmids	NULL
directed	NULL
by	NULL
the	NULL
AP-l-responsive	NULL
(	NULL
-78/+63	NULL
base	NULL
pairs	NULL
)	NULL
sequence	NULL
of	NULL
the	NULL
collagenase	NULL
promoter	NULL
(	NULL
-78colliuc	NULL
)	NULL
(	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
)	NULL
or	NULL
by	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
IL-2Luc	NULL
)	NULL
(	NULL
panels	NULL
C	NULL
and	NULL
D	NULL
)	NULL
together	NULL
with	NULL
10	NULL
ug/ml	NULL
expression	NULL
vectors	NULL
of	NULL
the	NULL
frans-dominant	NULL
negative	NULL
forms	NULL
of	NULL
ras	NULL
(	NULL
panels	NULL
A	NULL
and	NULL
C	NULL
)	NULL
and	NULL
rof	NULL
(	NULL
panels	NULL
B	NULL
and	NULL
D	NULL
)	NULL
or	NULL
its	NULL
parental	NULL
empty	NULL
vector	NULL
,	NULL
pEFBOS	NULL
,	NULL
for	NULL
12	NULL
h.	NULL
36	NULL
h	NULL
post-transfection	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
50	NULL
um	NULL
PDTC	NULL
or	NULL
20	NULL
ng/ml	NULL
PMA	NULL
plus	NULL
1	NULL
um	NULL
A28187	NULL
for	NULL
an	NULL
additional	NULL
12	NULL
h.	NULL
The	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
relative	NULL
light	NULL
units	NULL
(	NULL
R.L.U	NULL
)	NULL
measured	NULL
for	NULL
30	NULL
s.	NULL
Results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

transient	NULL
expression	NULL
of	NULL
c-fos	NULL
,	NULL
a	NULL
strong	NULL
and	NULL
prolonged	NULL
expression	NULL
of	NULL
c-jun	NULL
,	NULL
and	NULL
a	NULL
durable	NULL
activation	NULL
of	NULL
both	NULL
c-fos	NULL
and	NULL
c-jun	NULL
triggered	NULL
by	NULL
PMA	NULL
plus	NULL
ionophore	NULL
.	NULL

Effect	NULL
of	NULL
PDTC	NULL
on	NULL
the	NULL
Ras/ERK	NULL
Pathway-The	NULL
Ras/ERK	NULL
pathway	NULL
is	NULL
a	NULL
common	NULL
route	NULL
that	NULL
serves	NULL
multiple	NULL
extracellular	NULL
signals	NULL
that	NULL
activate	NULL
the	NULL
SRE	NULL
of	NULL
the	NULL
c-fos	NULL
promoter	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
SRE	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
act	NULL
as	NULL
a	NULL
primary	NULL
antioxidant	NULL
responsive	NULL
element	NULL
that	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
PDTC	NULL
(	NULL
23	NULL
)	NULL
,	NULL
we	NULL
analyzed	NULL
whether	NULL
the	NULL
activation	NULL
of	NULL
AP-1	NULL
by	NULL
this	NULL
antioxidant	NULL
was	NULL
mediated	NULL
through	NULL
activation	NULL
of	NULL
this	NULL
pathway	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
an	NULL
AP-1	NULL
reporter	NULL
construct	NULL
(	NULL
-73colLue	NULL
)	NULL
in	NULL
response	NULL
to	NULL
PDTC	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
dominant	NULL
negative	NULL
ras	NULL
,	NULL
c-Ha-ras	NULL
N17	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

The	NULL
efficient	NULL
expression	NULL
of	NULL
the	NULL
ras	NULL
construct	NULL
was	NULL
confirmed	NULL
in	NULL
parallel	NULL
cotransfections	NULL
,	NULL
where	NULL
expression	NULL
of	NULL
c-Ha-ras	NULL
N17	NULL
caused	NULL
a	NULL
severe	NULL
transcriptional	NULL
inhibition	NULL
of	NULL
both	NULL
a	NULL
luciferase	NULL
plasmid	NULL
directed	NULL
by	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
and	NULL
the	NULL
AP-1	NULL
reporter	NULL
plasmid	NULL
in	NULL
response	NULL
to	NULL
PMA	NULL
plus	NULL
ionophore	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Similar	NULL
experiments	NULL
were	NULL
performed	NULL
to	NULL
analyze	NULL
whether	NULL
Raf-1	NULL
kinase	NULL
was	NULL
required	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
AP-1	NULL
induced	NULL
by	NULL
PDTC	NULL
.	NULL

AP-1	NULL
frans-activation	NULL
by	NULL
the	NULL
antioxidant	NULL
was	NULL
not	NULL
significantly	NULL
affected	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
trans-dominant	NULL
negative	NULL
mutant	NULL
of	NULL
Raf-l1	NULL
kinase	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
which	NULL
efficiently	NULL
inhibited	NULL
the	NULL
IL-2Luc	NULL
frans-activation	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
AP-1Luc	NULL
trans-activation	NULL
by	NULL
PMA	NULL
plus	NULL
ionophore	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
explore	NULL
whether	NULL
the	NULL
signals	NULL
elicited	NULL
by	NULL
PDTC	NULL
affected	NULL
ERK	NULL
activity	NULL
,	NULL
we	NULL
performed	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
anti-Erk-1	NULL
,	NULL
-2	NULL
antibodies	NULL
to	NULL
detect	NULL
any	NULL
possible	NULL
decrease	NULL
in	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
ERKs	NULL
which	NULL
would	NULL
be	NULL
indicative	NULL
of	NULL
its	NULL
activation	NULL
(	NULL
41	NULL
)	NULL
.	NULL

PDTC	NULL
failed	NULL
to	NULL
modify	NULL
the	NULL
mobility	NULL
of	NULL
ERK-2	NULL
,	NULL
which	NULL
appears	NULL
to	NULL
be	NULL
the	NULL
predominant	NULL
ERK	NULL
isoform	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
26338	NULL
A	NULL
2	NULL
min	NULL
5	NULL
min	NULL
15	NULL
min	NULL
30	NULL
min	NULL
I	NULL
A	NULL
%	NULL
p42	NULL
C	NULL
-all	NULL
mpm	NULL
»	NULL
PDTC	NULL
£	NULL
5	NULL
min	NULL
£	NULL
an	NULL
a	NULL
£	NULL
E	NULL
£	NULL
o	NULL
r	NULL
w=	NULL
a	NULL
=t	NULL
w	NULL
Led	NULL
«	NULL
I	NULL
pC	NULL
m9	NULL
¥	NULL
zea	NULL
a	NULL
&	NULL
osi	NULL
PA	NULL
£5	NULL
:	NULL
s	NULL
s	NULL
z	NULL
1	NULL
€	NULL
5	NULL
a	NULL
&	NULL
=	NULL
z	NULL
®	NULL
o	NULL
u	NULL
»	NULL
0	NULL
a	NULL
bu	NULL
p42C	NULL
,	NULL
.	NULL

PMA/PDTC	NULL
B	NULL
PMA	NULL
PDTC	NULL
PMA/PDTC	NULL
-	NULL
45	NULL
90	NULL
180	NULL
45	NULL
90	NULL
180	NULL
45	NULL
90	NULL
180	NULL
min	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Effects	NULL
of	NULL
PDTC	NULL
and	NULL
PMA	NULL
on	NULL
ERK	NULL
activity	NULL
and	NULL
PAC-1	NULL
gene	NULL
expression	NULL
.	NULL

Panel	NULL
A	NULL
,	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
total	NULL
lysates	NULL
from	NULL
Jurkat	NULL
cells	NULL
(	NULL
10°	NULL
)	NULL
incubated	NULL
with	NULL
50	NULL
um	NULL
PDTC	NULL
,	NULL
20	NULL
ng/ml	NULL
PMA	NULL
,	NULL
or	NULL
preincubated	NULL
with	NULL
50	NULL
um	NULL
PDTC	NULL
for	NULL
2	NULL
h	NULL
and	NULL
then	NULL
treated	NULL
with	NULL
20	NULL
ng/ml	NULL
PMA	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

A	NULL
monoclonal	NULL
antibody	NULL
against	NULL
ERK-1	NULL
and	NULL
ERK-2	NULL
was	NULL
used	NULL
.	NULL

The	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
the	NULL
upper	NULL
and	NULL
lower	NULL
bands	NULL
corresponded	NULL
to	NULL
the	NULL
phosphorylated	NULL
and	NULL
unphosphorylated	NULL
bands	NULL
of	NULL
ERK-2	NULL
,	NULL
respectively	NULL
.	NULL

Panel	NULL
B	NULL
,	NULL
total	NULL
cytoplasmic	NULL
RNAs	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
from	NULL
Jurkat	NULL
cells	NULL
treated	NULL
as	NULL
described	NULL
in	NULL
panel	NULL
A	NULL
were	NULL
prepared	NULL
at	NULL
different	NULL
times	NULL
of	NULL
treatment	NULL
and	NULL
subjected	NULL
to	NULL
Northern	NULL
blot	NULL
analysis	NULL
using	NULL
a	NULL
probe	NULL
specific	NULL
for	NULL
PAC-1	NULL
.	NULL

expressed	NULL
by	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
PMA	NULL
caused	NULL
a	NULL
very	NULL
rapid	NULL
transient	NULL
shift	NULL
in	NULL
the	NULL
mobility	NULL
of	NULL
ERK-2	NULL
which	NULL
was	NULL
detected	NULL
as	NULL
early	NULL
as	NULL
30	NULL
s	NULL
and	NULL
declined	NULL
after	NULL
1	NULL
h	NULL
of	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
when	NULL
Jurkat	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
PDTC	NULL
and	NULL
stimulated	NULL
further	NULL
with	NULL
PMA	NULL
,	NULL
ERK-2	NULL
persisted	NULL
in	NULL
its	NULL
activated	NULL
form	NULL
after	NULL
24	NULL
h	NULL
of	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

The	NULL
persistent	NULL
phosphorylation	NULL
of	NULL
ERK-2	NULL
observed	NULL
might	NULL
be	NULL
due	NULL
to	NULL
an	NULL
inhibition	NULL
of	NULL
the	NULL
PAC-1	NULL
T	NULL
cell	NULL
phosphatase	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
dephosphorylate	NULL
ERK-2	NULL
in	NULL
vivo	NULL
(	NULL
34	NULL
,	NULL
42	NULL
)	NULL
.	NULL

However	NULL
,	NULL
Northern	NULL
blot	NULL
analysis	NULL
indicated	NULL
that	NULL
mRNA	NULL
steady-state	NULL
levels	NULL
of	NULL
PAC-1	NULL
,	NULL
induced	NULL
early	NULL
by	NULL
PMA	NULL
,	NULL
were	NULL
not	NULL
significantly	NULL
affected	NULL
by	NULL
previous	NULL
treatment	NULL
with	NULL
PDTC	NULL
after	NULL
90	NULL
and	NULL
180	NULL
min	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
when	NULL
a	NULL
complete	NULL
activation	NULL
of	NULL
ERK-2	NULL
was	NULL
found	NULL
in	NULL
cotreated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
Ras/Raf/ERK	NULL
pathway	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
mediate	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
antioxidant	NULL
PDTC	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
combined	NULL
treatment	NULL
of	NULL
PDTC	NULL
and	NULL
PMA	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
synergize	NULL
on	NULL
AP-1-dependent	NULL
trans-activation	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
caused	NULL
a	NULL
persistent	NULL
phosphorylation	NULL
of	NULL
ERK-2	NULL
by	NULL
mechanisms	NULL
different	NULL
from	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
gene	NULL
expression	NULL
of	NULL
PAC-1	NULL
.	NULL

Activation	NULL
of	NULL
JNK	NULL
by	NULL
Antioxidants-Signals	NULL
leading	NULL
to	NULL
T	NULL
cell	NULL
activation	NULL
by	NULL
costimulation	NULL
with	NULL
phorbol	NULL
ester	NULL
and	NULL
Ca**	NULL
ionophore	NULL
or	NULL
by	NULL
agonistic	NULL
antibodies	NULL
to	NULL
the	NULL
T	NULL
cell	NULL
receptor-CD3	NULL
complex	NULL
and	NULL
to	NULL
CD28	NULL
involve	NULL
the	NULL
activation	NULL
of	NULL
JNKs	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Besides	NULL
the	NULL
ability	NULL
to	NULL
phosphorylate	NULL
c-Jun	NULL
(	NULL
40	NULL
)	NULL
,	NULL
JNKs	NULL
have	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
phosphorylate	NULL
ATF-2	NULL
(	NULL
11	NULL
,	NULL
44	NULL
,	NULL
45	NULL
)	NULL
and	NULL
TCF-Elk-1	NULL
(	NULL
16-19	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
JNKs	NULL
phosphorylate	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
AP-1	NULL
not	NULL
only	NULL
by	NULL
regulating	NULL
c-jun	NULL
but	NULL
also	NULL
by	NULL
c-fos	NULL
transcription	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
decided	NULL
to	NULL
determine	NULL
whether	NULL
PDTC	NULL
affected	NULL
the	NULL
activity	NULL
of	NULL
JNKs	NULL
,	NULL
a	NULL
mechanism	NULL
that	NULL
could	NULL
account	NULL
for	NULL
the	NULL
observed	NULL
c-fos	NULL
and	NULL
c-jun	NULL
activation	NULL
in	NULL
the	NULL
apparent	NULL
absence	NULL
of	NULL
ERK	NULL
activation	NULL
.	NULL

In-gel	NULL
kinase	NULL
assays	NULL
of	NULL
GST-c-Jun	NULL
,	NULL
_	NULL
;	NULL
,	NULL
,	NULL
revealed	NULL
activation	NULL
of	NULL
the	NULL
46-	NULL
and	NULL
55-kDa	NULL
forms	NULL
of	NULL
JNK	NULL
in	NULL
extracts	NULL
of	NULL
Jurkat	NULL
cells	NULL
treated	NULL
with	NULL
PDTC	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Strikingly	NULL
,	NULL
whereas	NULL
the	NULL
treatment	NULL
with	NULL
either	NULL
PMA	NULL
plus	NULL
ionophore	NULL
or	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
resulted	NULL
in	NULL
a	NULL
transient	NULL
acti-	NULL
Antioxidants	NULL
Activate	NULL
JNK	NULL
CD3+	NULL
A	NULL
P+lo	NULL
PDTC	NULL
B	NULL
rim	NULL
cnr	NULL
-	NULL
0.25	NULL
104	NULL
8	NULL
0.25	NULL
1	NULL
4	NULL
80	NULL
0	NULL
-	NULL
0.25	NULL
0.25	NULL
2	NULL
hours	NULL
||	NULL
#	NULL
TC	NULL
w	NULL
``	NULL
<	NULL
-	NULL
55	NULL
kDa	NULL
Go-	NULL
-	NULL
«	NULL
-	NULL
<	NULL
apegp	NULL
«	NULL
aw	NULL
<	NULL
-	NULL
46	NULL
kDa	NULL
C	NULL
NAC	NULL
P+lo	NULL
D	NULL
P+lo	NULL
_	NULL
BHA	NULL
-	NULL
0.250	NULL
1	NULL
40	NULL
0.25	NULL
-	NULL
0.25	NULL
1	NULL
4	NULL
-	NULL
hours	NULL
CHB	NULL
ws	NULL
«	NULL
at	NULL
SB	NULL
|	NULL
«	NULL
-	NULL
55	NULL
kDa	NULL
«	NULL
un	NULL
me	NULL
|	NULL
<	NULL
-	NULL
46	NULL
kDa	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Activation	NULL
of	NULL
JNK	NULL
by	NULL
antioxidants	NULL
and	NULL
T	NULL
cell	NULL
stimuli	NULL
.	NULL

In-gel	NULL
kinase	NULL
assay	NULL
performed	NULL
with	NULL
whole-cell	NULL
extracts	NULL
from	NULL
Jurkat	NULL
cells	NULL
(	NULL
10°	NULL
)	NULL
treated	NULL
with	NULL
20	NULL
ng/ml	NULL
PMA	NULL
plus	NULL
1	NULL
um	NULL
A23187	NULL
(	NULL
P+J0	NULL
)	NULL
,	NULL
or	NULL
100	NULL
uM	NULL
PDTC	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
,	NULL
10	NULL
pg/ml	NULL
anti-CD3	NULL
plus	NULL
2	NULL
ug/ml	NULL
anti-CD28	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
N-acetylcysteine	NULL
(	NULL
NAC	NULL
,	NULL
panel	NULL
C	NULL
)	NULL
,	NULL
and	NULL
50	NULL
uM	NULL
BHA	NULL
(	NULL
panel	NULL
D	NULL
)	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

Controls	NULL
from	NULL
untreated	NULL
and	NULL
PMA	NULL
plus	NULL
iono-phore-treated	NULL
cells	NULL
are	NULL
included	NULL
in	NULL
each	NULL
experiment	NULL
to	NULL
compare	NULL
the	NULL
relative	NULL
induction	NULL
obtained	NULL
with	NULL
the	NULL
different	NULL
antioxidants	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
separated	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
on	NULL
a	NULL
gel	NULL
polymerized	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GST-c-Jun	NULL
,	NULL
_	NULL
;	NULL
,	NULL
.	NULL

After	NULL
a	NULL
denaturation-renaturation	NULL
process	NULL
,	NULL
the	NULL
gel	NULL
was	NULL
incubated	NULL
with	NULL
[	NULL
y-°	NULL
]	NULL
ATP	NULL
,	NULL
washed	NULL
extensively	NULL
,	NULL
and	NULL
exposed	NULL
.	NULL

The	NULL
bands	NULL
corresponding	NULL
to	NULL
the	NULL
46-	NULL
and	NULL
55-kDa	NULL
JNK	NULL
forms	NULL
are	NULL
indicated	NULL
by	NULL
arrowheads	NULL
.	NULL

vation	NULL
of	NULL
JNK	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
,	NULL
PDTC	NULL
exerted	NULL
a	NULL
prolonged	NULL
activation	NULL
of	NULL
JNK	NULL
which	NULL
was	NULL
maintained	NULL
for	NULL
at	NULL
least	NULL
8	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
activation	NULL
by	NULL
PDTC	NULL
was	NULL
due	NULL
to	NULL
its	NULL
antioxidant	NULL
effect	NULL
,	NULL
we	NULL
then	NULL
analyzed	NULL
the	NULL
effects	NULL
on	NULL
JNK	NULL
activity	NULL
of	NULL
two	NULL
structurally	NULL
unrelated	NULL
antioxidants	NULL
,	NULL
N-acetylcysteine	NULL
and	NULL
BHA	NULL
,	NULL
which	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
increase	NULL
AP-1	NULL
activity	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Exposure	NULL
of	NULL
Jurkat	NULL
cells	NULL
to	NULL
BHA	NULL
resulted	NULL
in	NULL
a	NULL
weak	NULL
although	NULL
sustained	NULL
activation	NULL
of	NULL
JNK	NULL
which	NULL
persisted	NULL
for	NULL
more	NULL
than	NULL
4	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
.	NULL

Treatment	NULL
with	NULL
N-acetylcysteine	NULL
led	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
to	NULL
a	NULL
transient	NULL
activation	NULL
of	NULL
JNK	NULL
,	NULL
although	NULL
in	NULL
this	NULL
case	NULL
it	NULL
was	NULL
even	NULL
stronger	NULL
than	NULL
that	NULL
mediated	NULL
by	NULL
PMA	NULL
plus	NULL
ionophore	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
signals	NULL
triggered	NULL
by	NULL
different	NULL
antioxidant	NULL
agents	NULL
that	NULL
increase	NULL
or	NULL
activate	NULL
AP-1	NULL
involve	NULL
the	NULL
activation	NULL
of	NULL
JNK	NULL
.	NULL

Inhibitors	NULL
of	NULL
T	NULL
Cell	NULL
Activation	NULL
Discriminate	NULL
the	NULL
Signaling	NULL
Pathways	NULL
of	NULL
PDTC	NULL
versus	NULL
PMA	NULL
plus	NULL
Ionophore-To	NULL
search	NULL
for	NULL
mechanisms	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
JNK	NULL
by	NULL
antioxidant	NULL
agents	NULL
,	NULL
a	NULL
panel	NULL
of	NULL
inhibitors	NULL
that	NULL
interfere	NULL
with	NULL
upstream	NULL
signals	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
was	NULL
used	NULL
.	NULL

Thus	NULL
,	NULL
inhibition	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
with	NULL
herbimycin	NULL
A	NULL
resulted	NULL
in	NULL
significant	NULL
inhibition	NULL
of	NULL
the	NULL
JNK	NULL
activation	NULL
mediated	NULL
by	NULL
PMA	NULL
plus	NULL
ionophore	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
and	NULL
by	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
antibodies	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
but	NULL
it	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
that	NULL
mediated	NULL
by	NULL
PDTC	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
blockade	NULL
of	NULL
the	NULL
Ca**/calcineurin	NULL
signaling	NULL
pathway	NULL
with	NULL
cyclosporin	NULL
A	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
attenuate	NULL
JNK	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
either	NULL
PMA	NULL
plus	NULL
ionophore	NULL
or	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
(	NULL
43	NULL
)	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
PDTC-mediated	NULL
JNK	NULL
activation	NULL
at	NULL
the	NULL
doses	NULL
analyzed	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
inhibition	NULL
of	NULL
PKC	NULL
with	NULL
bisindolylmaleimide	NULL
(	NULL
46	NULL
)	NULL
,	NULL
which	NULL
completely	NULL
abrogated	NULL
the	NULL
activation	NULL
of	NULL
JNK	NULL
induced	NULL
by	NULL
PMA	NULL
plus	NULL
ionophore	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
,	NULL
had	NULL
the	NULL
opposite	NULL
effect	NULL
on	NULL
the	NULL
PDTC-mediated	NULL
activation	NULL
,	NULL
resulting	NULL
in	NULL
increased	NULL
JNK	NULL
activity	NULL
when	NULL
bisindolylmaleimide	NULL
was	NULL
added	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
,	NULL
which	NULL
was	NULL
not	NULL
observed	NULL
either	NULL
with	NULL
extracts	NULL
from	NULL
cells	NULL
treated	NULL
with	NULL
PMA	NULL
plus	NULL
ionophore	NULL
,	NULL
with	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
cells	NULL
,	NULL
or	NULL
with	NULL
control	NULL
cells	NULL
pretreated	NULL
with	NULL
the	NULL
PKC	NULL
inhibitor	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
requires	NULL
further	NULL
study	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
bisindolylmaleimide	NULL
clearly	NULL
discriminates	NULL
the	NULL
signaling	NULL
pathways	NULL
induced	NULL
by	NULL
PDTC	NULL
versus	NULL
PMA	NULL
plus	NULL
ionophore	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
signals	NULL
that	NULL
converge	NULL
in	NULL
JNK	NULL
activation	NULL
mediated	NULL
by	NULL
PDTC	NULL
appear	NULL
to	NULL
be	NULL
distinct	NULL
from	NULL
those	NULL
elicited	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Antioxidants	NULL
Activate	NULL
JNK	NULL
A	NULL
P+Io	NULL
=	NULL
``	NULL
_	NULL
BSM	NULL
CsA	NULL
Herb	NULL
Hie	NULL
<	NULL
-	NULL
55	NULL
kDa	NULL
=	NULL
sal	NULL
+-	NULL
46	NULL
kDa	NULL
wa	NULL
B	NULL
PDTC	NULL
20	NULL
aM	NULL
PDTC	NULL
100	NULL
M	NULL
-	NULL
P+Io	NULL
=	NULL
=	NULL
BSM	NULL
CsA	NULL
Herb	NULL
-	NULL
BSM	NULL
CsA	NULL
Herb	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Effects	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
inhibitors	NULL
on	NULL
the	NULL
JNK	NULL
activity	NULL
induced	NULL
by	NULL
PDTC	NULL
and	NULL
T	NULL
cell	NULL
stimuli	NULL
.	NULL

In-gel	NULL
kinase	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
whole-cell	NULL
extracts	NULL
from	NULL
Jurkat	NULL
cells	NULL
preincubated	NULL
or	NULL
not	NULL
with	NULL
10	NULL
uM	NULL
bisindolylmaleimide	NULL
(	NULL
BSM	NULL
)	NULL
,	NULL
100	NULL
ng/ml	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
,	NULL
or	NULL
800	NULL
nM	NULL
herbimycin	NULL
A	NULL
(	NULL
Herb	NULL
)	NULL
for	NULL
4	NULL
,	NULL
1	NULL
,	NULL
and	NULL
12	NULL
h	NULL
,	NULL
respectively	NULL
.	NULL

After	NULL
preincubation	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
20	NULL
ng/ml	NULL
PMA	NULL
plus	NULL
1	NULL
uM	NULL
A23187	NULL
(	NULL
P+I0	NULL
)	NULL
for	NULL
15	NULL
min	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
or	NULL
with	NULL
20	NULL
and	NULL
100	NULL
um	NULL
PDTC	NULL
for	NULL
2	NULL
h	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
then	NULL
obtained	NULL
,	NULL
and	NULL
an	NULL
in-gel	NULL
kinase	NULL
assay	NULL
of	NULL
GST-c-Jun	NULL
,	NULL
_	NULL
;	NULL
,	NULL
was	NULL
performed	NULL
.	NULL

The	NULL
bands	NULL
corresponding	NULL
to	NULL
the	NULL
55-	NULL
and	NULL
46-kDa	NULL
forms	NULL
of	NULL
JNK	NULL
are	NULL
indicated	NULL
by	NULL
arrowheads	NULL
.	NULL

through	NULL
stimulation	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
PMA	NULL
plus	NULL
ionophore	NULL
or	NULL
anti-CD3	NULL
plus	NULL
CD28	NULL
.	NULL

DISCUSSION	NULL
The	NULL
physiological	NULL
and	NULL
pharmacological	NULL
modifications	NULL
of	NULL
the	NULL
cellular	NULL
redox	NULL
state	NULL
provoke	NULL
drastic	NULL
changes	NULL
in	NULL
the	NULL
activities	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
AP-1	NULL
and	NULL
NFkB	NULL
which	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
immune	NULL
response	NULL
.	NULL

NFB	NULL
and	NULL
AP-1	NULL
are	NULL
affected	NULL
differentially	NULL
by	NULL
signals	NULL
generated	NULL
by	NULL
prooxidant	NULL
and	NULL
antioxidant	NULL
agents	NULL
(	NULL
20	NULL
)	NULL
;	NULL
whereas	NULL
NFkB	NULL
is	NULL
induced	NULL
by	NULL
a	NULL
large	NULL
number	NULL
of	NULL
T	NULL
cell	NULL
stimuli	NULL
that	NULL
cause	NULL
reactive	NULL
oxygen	NULL
intermediate	NULL
generation	NULL
(	NULL
20	NULL
,	NULL
47	NULL
)	NULL
,	NULL
its	NULL
activation	NULL
is	NULL
inhibited	NULL
by	NULL
different	NULL
antioxidant	NULL
agents	NULL
with	NULL
radical	NULL
scavenger	NULL
properties	NULL
.	NULL

However	NULL
,	NULL
AP-1	NULL
is	NULL
not	NULL
only	NULL
induced	NULL
by	NULL
a	NULL
wide	NULL
array	NULL
of	NULL
stimuli	NULL
that	NULL
generate	NULL
oxidative	NULL
stress	NULL
(	NULL
23	NULL
,	NULL
28-31	NULL
)	NULL
,	NULL
but	NULL
also	NULL
by	NULL
a	NULL
number	NULL
of	NULL
antioxidant	NULL
agents	NULL
(	NULL
23-25	NULL
,	NULL
32	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
signaling	NULL
pathways	NULL
through	NULL
which	NULL
antioxidants	NULL
and	NULL
T	NULL
cell	NULL
stimuli	NULL
lead	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
AP-1	NULL
and	NULL
identify	NULL
JNK	NULL
as	NULL
a	NULL
target	NULL
activated	NULL
by	NULL
different	NULL
antioxidant	NULL
agents	NULL
.	NULL

Although	NULL
treatment	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
either	NULL
PMA	NULL
plus	NULL
ionophore	NULL
or	NULL
anti	NULL
TCR/CD3	NULL
plus	NULL
CD28	NULL
on	NULL
one	NULL
hand	NULL
and	NULL
with	NULL
antioxidants	NULL
on	NULL
the	NULL
other	NULL
increases	NULL
the	NULL
activity	NULL
of	NULL
JNK	NULL
,	NULL
our	NULL
data	NULL
clearly	NULL
indicate	NULL
that	NULL
the	NULL
signal	NULL
transduction	NULL
mechanisms	NULL
involved	NULL
in	NULL
both	NULL
activations	NULL
are	NULL
different	NULL
.	NULL

(	NULL
i	NULL
)	NULL
JNK	NULL
activation	NULL
by	NULL
PDTC	NULL
was	NULL
refractory	NULL
to	NULL
inhibitors	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
,	NULL
or	NULL
Ca**	NULL
signaling	NULL
,	NULL
whereas	NULL
the	NULL
JNK	NULL
activation	NULL
mediated	NULL
by	NULL
either	NULL
T	NULL
cell	NULL
receptor-CD3/CD28	NULL
antibodies	NULL
or	NULL
PMA	NULL
plus	NULL
ionophore	NULL
was	NULL
inhibited	NULL
to	NULL
a	NULL
variable	NULL
extent	NULL
by	NULL
such	NULL
inhibitors	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
TRE	NULL
and	NULL
IL-2	NULL
promoter-mediated	NULL
frans-activation	NULL
by	NULL
PMA	NULL
and	NULL
ionophore	NULL
was	NULL
sensitive	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
trans-dominant	NULL
negative	NULL
versions	NULL
of	NULL
ras	NULL
and	NULL
raf	NULL
which	NULL
failed	NULL
to	NULL
inhibit	NULL
the	NULL
AP-1	NULL
trans-activation	NULL
induced	NULL
by	NULL
PDTC	NULL
.	NULL

(	NULL
iii	NULL
)	NULL
Transient	NULL
phosphorylation	NULL
of	NULL
ERK-2	NULL
,	NULL
detected	NULL
at	NULL
early	NULL
times	NULL
of	NULL
activation	NULL
with	NULL
PMA	NULL
,	NULL
was	NULL
not	NULL
observed	NULL
after	NULL
treatment	NULL
with	NULL
PDTC	NULL
.	NULL

Although	NULL
the	NULL
expression	NULL
of	NULL
c-Ha-ras	NULL
N17	NULL
dominant	NULL
negative	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
trans-activation	NULL
of	NULL
AP-1	NULL
by	NULL
PDTC	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
,	NULL
this	NULL
was	NULL
augmented	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
constitutively	NULL
active	NULL
v-Ha-ras	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Since	NULL
activated	NULL
Ha-ras	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
partially	NULL
activate	NULL
JNK	NULL
(	NULL
10	NULL
)	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
additional	NULL
effect	NULL
displayed	NULL
by	NULL
activated	NULL
ras	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
AP-1	NULL
26339	NULL
by	NULL
PDTC	NULL
is	NULL
mediated	NULL
through	NULL
JNK	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
Ras/RafERK	NULL
pathway	NULL
can	NULL
modulate	NULL
the	NULL
PDTC-induced	NULL
signaling	NULL
to	NULL
AP-1	NULL
,	NULL
although	NULL
it	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
mediate	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
antioxidant	NULL
.	NULL

An	NULL
interesting	NULL
feature	NULL
of	NULL
ERK	NULL
regulation	NULL
arising	NULL
during	NULL
the	NULL
analysis	NULL
of	NULL
its	NULL
phosphorylation	NULL
in	NULL
extracts	NULL
of	NULL
Jurkat	NULL
cells	NULL
cotreated	NULL
with	NULL
PMA	NULL
and	NULL
PDTC	NULL
was	NULL
the	NULL
persistent	NULL
activated	NULL
state	NULL
of	NULL
ERK-2	NULL
.	NULL

Whether	NULL
this	NULL
prolonged	NULL
activation	NULL
is	NULL
related	NULL
to	NULL
the	NULL
synergism	NULL
observed	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
AP-1	NULL
by	NULL
both	NULL
agents	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
remains	NULL
to	NULL
be	NULL
investigated	NULL
further	NULL
.	NULL

Since	NULL
PAC-1	NULL
is	NULL
a	NULL
phosphatase	NULL
rapidly	NULL
expressed	NULL
after	NULL
T	NULL
cell	NULL
activation	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
ERK-2	NULL
phosphorylation	NULL
and	NULL
activation	NULL
(	NULL
34	NULL
,	NULL
42	NULL
)	NULL
,	NULL
we	NULL
have	NULL
analyzed	NULL
its	NULL
involvement	NULL
in	NULL
the	NULL
activation	NULL
induced	NULL
by	NULL
PMA	NULL
plus	NULL
PDTC	NULL
.	NULL

However	NULL
,	NULL
our	NULL
studies	NULL
on	NULL
PAC-1	NULL
gene	NULL
expression	NULL
indicated	NULL
that	NULL
PAC-1	NULL
mRNA	NULL
levels	NULL
induced	NULL
by	NULL
PMA	NULL
were	NULL
not	NULL
significantly	NULL
affected	NULL
by	NULL
PDTC	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Other	NULL
explanations	NULL
that	NULL
could	NULL
account	NULL
for	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
ERK	NULL
include	NULL
the	NULL
possibility	NULL
that	NULL
PAC-1	NULL
phosphatase	NULL
activity	NULL
was	NULL
post-transcriptionally	NULL
inhibited	NULL
by	NULL
PDTC	NULL
,	NULL
or	NULL
more	NULL
likely	NULL
,	NULL
that	NULL
other	NULL
phosphatases	NULL
could	NULL
be	NULL
inhibited	NULL
by	NULL
the	NULL
antioxidant	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
phosphatase-1	NULL
in	NULL
T	NULL
lymphocytes	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
block	NULL
PMA-induced	NULL
ERK	NULL
activity	NULL
and	NULL
to	NULL
inhibit	NULL
IL-2	NULL
promoter-dependent	NULL
transcription	NULL
in	NULL
response	NULL
to	NULL
PMA	NULL
plus	NULL
ionophore	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Since	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
phosphatase-1	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
dephosphorylate	NULL
JNK	NULL
(	NULL
49	NULL
)	NULL
,	NULL
it	NULL
will	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
study	NULL
the	NULL
activity	NULL
and	NULL
expression	NULL
of	NULL
this	NULL
phosphatase	NULL
in	NULL
response	NULL
to	NULL
antioxidants	NULL
.	NULL

In	NULL
HeLa	NULL
cells	NULL
PDTC	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
c-fos	NULL
and	NULL
c-jun	NULL
transcription	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Although	NULL
we	NULL
have	NULL
found	NULL
induction	NULL
of	NULL
both	NULL
c-fos	NULL
and	NULL
c-jun	NULL
by	NULL
PDTC	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
important	NULL
kinetic	NULL
differences	NULL
are	NULL
observed	NULL
when	NULL
both	NULL
cell	NULL
types	NULL
are	NULL
compared	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
Hela	NULL
cells	NULL
PDTC	NULL
triggers	NULL
c-fos	NULL
gene	NULL
expression	NULL
faster	NULL
than	NULL
c-jun	NULL
,	NULL
with	NULL
a	NULL
transient	NULL
induction	NULL
in	NULL
both	NULL
cases	NULL
(	NULL
23	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
Jurkat	NULL
cells	NULL
PDTC-mediated	NULL
c-jun	NULL
expression	NULL
was	NULL
prolonged	NULL
and	NULL
preceded	NULL
that	NULL
of	NULL
c-fos	NULL
.	NULL

Therefore	NULL
,	NULL
PDTC	NULL
can	NULL
operate	NULL
by	NULL
different	NULL
mechanisms	NULL
depending	NULL
on	NULL
the	NULL
cell	NULL
type	NULL
analyzed	NULL
.	NULL

The	NULL
SRE	NULL
within	NULL
the	NULL
c-fos	NULL
promoter	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
act	NULL
as	NULL
a	NULL
primary	NULL
antioxidant	NULL
element	NULL
that	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
PDTC	NULL
in	NULL
Hela	NULL
cells	NULL
(	NULL
23	NULL
)	NULL
.	NULL

However	NULL
,	NULL
as	NULL
discussed	NULL
above	NULL
,	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
the	NULL
antioxidant	NULL
acted	NULL
in	NULL
Jurkat	NULL
cells	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
the	NULL
Ras/Raf/ERK	NULL
pathway	NULL
.	NULL

Hence	NULL
,	NULL
PDTC	NULL
seems	NULL
to	NULL
be	NULL
one	NULL
of	NULL
the	NULL
stimuli	NULL
that	NULL
can	NULL
induce	NULL
c-fos	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
ERK	NULL
activation	NULL
.	NULL

Since	NULL
JNK	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
phosphorylate	NULL
TCF/EIk-1	NULL
,	NULL
the	NULL
major	NULL
transcription	NULL
factor	NULL
involved	NULL
in	NULL
SRE	NULL
activation	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
PDTC	NULL
can	NULL
activate	NULL
c-fos	NULL
transcription	NULL
through	NULL
the	NULL
phosphorylation	NULL
of	NULL
TCF	NULL
by	NULL
JNK	NULL
.	NULL

Additional	NULL
experiments	NULL
,	NULL
including	NULL
in-gel	NULL
kinase	NULL
analysis	NULL
of	NULL
GST-EIk-1	NULL
in	NULL
extracts	NULL
of	NULL
cells	NULL
treated	NULL
with	NULL
antioxidants	NULL
,	NULL
will	NULL
be	NULL
required	NULL
to	NULL
elucidate	NULL
this	NULL
issue	NULL
.	NULL

We	NULL
have	NULL
found	NULL
that	NULL
structurally	NULL
unrelated	NULL
antioxidant	NULL
agents	NULL
activate	NULL
JNK	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
kinetics	NULL
and	NULL
strength	NULL
of	NULL
this	NULL
activation	NULL
as	NULL
well	NULL
as	NULL
the	NULL
abilities	NULL
to	NULL
stimulate	NULL
AP-1	NULL
displayed	NULL
by	NULL
the	NULL
different	NULL
antioxidants	NULL
are	NULL
different	NULL
.	NULL

Thus	NULL
,	NULL
PDTC	NULL
per	NULL
se	NULL
exerts	NULL
a	NULL
potent	NULL
and	NULL
prolonged	NULL
JNK	NULL
activation	NULL
and	NULL
activates	NULL
both	NULL
AP-1	NULL
DNA	NULL
binding	NULL
activity	NULL
and	NULL
the	NULL
TRE-dependent	NULL
trans-activation	NULL
.	NULL

BHA	NULL
displays	NULL
a	NULL
weak	NULL
but	NULL
sustained	NULL
activation	NULL
of	NULL
JNK	NULL
;	NULL
and	NULL
N-acetylcysteine	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
AP-1	NULL
binding	NULL
but	NULL
not	NULL
significant	NULL
TRE	NULL
trans-activation	NULL
(	NULL
23	NULL
)	NULL
,	NULL
exerts	NULL
a	NULL
transient	NULL
activation	NULL
of	NULL
JNK	NULL
.	NULL

Moreover	NULL
,	NULL
N-acetylcysteine	NULL
was	NULL
the	NULL
strongest	NULL
antioxidant	NULL
stimulating	NULL
JNK	NULL
.	NULL

Therefore	NULL
,	NULL
sustained	NULL
activation	NULL
of	NULL
JNK	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
mechanism	NULL
through	NULL
which	NULL
some	NULL
antioxidants	NULL
can	NULL
operate	NULL
,	NULL
but	NULL
it	NULL
is	NULL
not	NULL
a	NULL
general	NULL
mechanism	NULL
that	NULL
mediates	NULL
the	NULL
signaling	NULL
of	NULL
all	NULL
of	NULL
the	NULL
antioxidants	NULL
.	NULL

Likewise	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
additional	NULL
signaling	NULL
,	NULL
different	NULL
from	NULL
JNK	NULL
activation	NULL
,	NULL
must	NULL
be	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
26340	NULL
required	NULL
to	NULL
activate	NULL
TRE-dependent	NULL
transcription	NULL
,	NULL
since	NULL
N-acetylcysteine	NULL
,	NULL
which	NULL
is	NULL
not	NULL
able	NULL
to	NULL
activate	NULL
it	NULL
per	NULL
se	NULL
(	NULL
23	NULL
,	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
activates	NULL
JNK	NULL
in	NULL
a	NULL
fashion	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
PMA	NULL
plus	NULL
ionophore	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
note	NULL
that	NULL
both	NULL
prooxidant	NULL
and	NULL
antioxidant	NULL
conditions	NULL
lead	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
AP-1	NULL
.	NULL

JNK	NULL
appears	NULL
to	NULL
be	NULL
tuned	NULL
differentially	NULL
under	NULL
both	NULL
conditions	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
would	NULL
be	NULL
possible	NULL
that	NULL
those	NULL
antioxidants	NULL
that	NULL
trigger	NULL
sustained	NULL
activation	NULL
of	NULL
JNK	NULL
might	NULL
elicit	NULL
specific	NULL
antioxidative	NULL
responses	NULL
through	NULL
AP-l-regulated	NULL
genes	NULL
,	NULL
subtly	NULL
regulated	NULL
by	NULL
the	NULL
duration	NULL
and	NULL
the	NULL
strength	NULL
of	NULL
JNK	NULL
stimulation	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
in	NULL
PC12	NULL
cells	NULL
the	NULL
cellular	NULL
responses	NULL
elicited	NULL
by	NULL
growth	NULL
factors	NULL
which	NULL
lead	NULL
cells	NULL
to	NULL
proliferate	NULL
or	NULL
to	NULL
differentiate	NULL
seem	NULL
to	NULL
be	NULL
determined	NULL
by	NULL
the	NULL
transient	NULL
or	NULL
sustained	NULL
activation	NULL
of	NULL
ERK	NULL
,	NULL
respectively	NULL
(	NULL
5	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
recently	NULL
that	NULL
several	NULL
dithiocarbamates	NULL
,	NULL
including	NULL
PDTC	NULL
,	NULL
trigger	NULL
mye-loid	NULL
differentiation	NULL
involving	NULL
the	NULL
activation	NULL
of	NULL
AP-1	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
it	NULL
will	NULL
be	NULL
of	NULL
the	NULL
utmost	NULL
interest	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
duration	NULL
of	NULL
JNK	NULL
activation	NULL
is	NULL
involved	NULL
in	NULL
selectively	NULL
triggering	NULL
these	NULL
cellular	NULL
responses	NULL
.	NULL

Future	NULL
experiments	NULL
will	NULL
be	NULL
designed	NULL
to	NULL
identify	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
antioxidants	NULL
target	NULL
JNK	NULL
activity	NULL
including	NULL
their	NULL
effects	NULL
on	NULL
the	NULL
upstream	NULL
signaling	NULL
pathway	NULL
components	NULL
that	NULL
activate	NULL
JNK/SAPKs	NULL
and	NULL
on	NULL
the	NULL
phosphatases	NULL
that	NULL
regulate	NULL
its	NULL
phosphorylation	NULL
.	NULL

These	NULL
studies	NULL
,	NULL
which	NULL
could	NULL
also	NULL
contribute	NULL
to	NULL
trace	NULL
the	NULL
signal	NULL
transduction	NULL
mechanisms	NULL
involved	NULL
in	NULL
T	NULL
lymphocyte	NULL
activation	NULL
,	NULL
are	NULL
currently	NULL
in	NULL
progress	NULL
.	NULL

Acknowledgments-We	NULL
are	NULL
very	NULL
grateful	NULL
to	NULL
Drs	NULL
.	NULL

P.	NULL
Angel	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
D.	NULL
Cantrell	NULL
,	NULL
G.	NULL
Crabtree	NULL
,	NULL
R.	NULL
J.	NULL
Davis	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
J.	NULL
Lépez-Fer-nandez	NULL
,	NULL
and	NULL
D.	NULL
Olive	NULL
for	NULL
providing	NULL
plasmids	NULL
and	NULL
antibodies	NULL
,	NULL
critical	NULL
reagents	NULL
that	NULL
have	NULL
made	NULL
this	NULL
work	NULL
possible	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Drs	NULL
.	NULL

M.	NULL
O.	NULL
de	NULL
Landgzuri	NULL
,	NULL
F.	NULL
Sinchez-Madrid	NULL
,	NULL
B.	NULL
Alarcon	NULL
,	NULL
and	NULL
M.	NULL
Lépez-Cabrera	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
Eva	NULL
Moreno	NULL
for	NULL
excellent	NULL
secretarial	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1072	NULL
,	NULL
129-157	NULL
.	NULL

Karin	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
16483-16486	NULL
.	NULL

Treisman	NULL
,	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

17	NULL
,	NULL
428-426	NULL
.	NULL

Hill	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
and	NULL
Treisman	NULL
,	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
80	NULL
,	NULL
199-211	NULL
.	NULL

Marshall	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Cell	NULL
80	NULL
,	NULL
179-185	NULL
.	NULL

Gille	NULL
,	NULL
H.	NULL
,	NULL
Sharrocks	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
and	NULL
Shaw	NULL
,	NULL
P.	NULL
E.	NULL
(	NULL
1992	NULL
)	NULL
Nature	NULL
858	NULL
,	NULL
414-417	NULL
.	NULL

Marais	NULL
,	NULL
R.	NULL
,	NULL
Wynne	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Treisman	NULL
,	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Cell	NULL
78	NULL
,	NULL
881-393	NULL
.	NULL

Zinck	NULL
,	NULL
R.	NULL
,	NULL
Hipskind	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Pingoud	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Nordheim	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
2377-2387	NULL
.	NULL

Davis	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Reprod	NULL
.	NULL

Dev	NULL
.	NULL

42	NULL
,	NULL
459-467	NULL
.	NULL

Dérijard	NULL
,	NULL
B.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Wu	NULL
,	NULL
L.-H.	NULL
,	NULL
Barrett	NULL
,	NULL
T.	NULL
,	NULL
Su	NULL
,	NULL
B.	NULL
,	NULL
Deng	NULL
,	NULL
T.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Davis	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cell	NULL
76	NULL
,	NULL
1025-1037	NULL
11	NULL
.	NULL

Gupta	NULL
,	NULL
S.	NULL
,	NULL
Campbell	NULL
,	NULL
D.	NULL
,	NULL
Dérijard	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Davis	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Science	NULL
267	NULL
,	NULL
389-393	NULL
12	NULL
.	NULL

Cano	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Mahadevan	NULL
,	NULL
L.	NULL
C.	NULL
(	NULL
1995	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

20	NULL
,	NULL
117-121	NULL
13	NULL
.	NULL

Cahill	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Janknecht	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Nordheim	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Curr	NULL
.	NULL

Biol	NULL
.	NULL

6	NULL
,	NULL
16-19	NULL
14	NULL
.	NULL

Biischer	NULL
,	NULL
M.	NULL
,	NULL
Rahmsdorf	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Litfin	NULL
,	NULL
M.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Herrlich	NULL
,	NULL
P.	NULL
(	NULL
1988	NULL
)	NULL
go	NULL
~1	NULL
®	NULL
Oum	NULL
to	NULL
N	NULL
1	NULL
0	NULL
w	NULL
Antioxidants	NULL
Activate	NULL
JNK	NULL
Oncogene	NULL
8	NULL
,	NULL
301-311	NULL
15	NULL
.	NULL

Cano	NULL
,	NULL
E.	NULL
,	NULL
Hazzalin	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Mahadevan	NULL
,	NULL
L.	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
7352-7362	NULL
16	NULL
.	NULL

Whitmarsh	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Shore	NULL
,	NULL
P.	NULL
,	NULL
Sharrocks	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
and	NULL
Davis	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Science	NULL
269	NULL
,	NULL
403-407	NULL
17	NULL
.	NULL

Zinck	NULL
,	NULL
R.	NULL
,	NULL
Cahill	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Kracht	NULL
,	NULL
M.	NULL
,	NULL
Sachsenmaier	NULL
,	NULL
C.	NULL
,	NULL
Hipskind	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Nordheim	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

15	NULL
,	NULL
4930-4938	NULL
18	NULL
.	NULL

Gille	NULL
,	NULL
H.	NULL
,	NULL
Strahl	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Shaw	NULL
,	NULL
P.	NULL
E.	NULL
(	NULL
1995	NULL
)	NULL
Curr	NULL
.	NULL

Biol	NULL
.	NULL

5	NULL
,	NULL
1191-1200	NULL
19	NULL
.	NULL

Cavigelli	NULL
,	NULL
M.	NULL
,	NULL
Dolfi	NULL
,	NULL
F.	NULL
,	NULL
Claret	NULL
,	NULL
F.-X	NULL
.	NULL

,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

14	NULL
,	NULL
5957-5964	NULL
20	NULL
.	NULL

Schulze-Osthoff	NULL
,	NULL
K.	NULL
,	NULL
Los	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Biochem	NULL
.	NULL

Pharmacol	NULL
.	NULL

50	NULL
,	NULL
7385-774	NULL
21	NULL
.	NULL

Staal	NULL
,	NULL
F.	NULL
J.	NULL
T.	NULL
,	NULL
Roederer	NULL
,	NULL
M.	NULL
,	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
and	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
9943-9947	NULL
22	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
Meier	NULL
,	NULL
B.	NULL
,	NULL
Minnel	NULL
,	NULL
D.	NULL
N.	NULL
,	NULL
Drige	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175	NULL
,	NULL
1181-1194	NULL
28	NULL
.	NULL

Meyer	NULL
,	NULL
M.	NULL
,	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
2005-2015	NULL
24	NULL
.	NULL

Schenk	NULL
,	NULL
H.	NULL
,	NULL
Matthias	NULL
,	NULL
K.	NULL
,	NULL
Erdbriigger	NULL
,	NULL
W.	NULL
,	NULL
Drige	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Schulze-Osthoff	NULL
,	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
1672-1676	NULL
25	NULL
.	NULL

Schulze-Osthoff	NULL
,	NULL
K.	NULL
,	NULL
Schenk	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Drige	NULL
,	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

252	NULL
,	NULL
253-264	NULL
26	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
Rieber	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
2247-2258	NULL
27	NULL
.	NULL

Mihm	NULL
,	NULL
S.	NULL
,	NULL
Ennen	NULL
,	NULL
J.	NULL
,	NULL
Pessara	NULL
,	NULL
U.	NULL
,	NULL
Kurth	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Drige	NULL
,	NULL
W.	NULL
(	NULL
1991	NULL
)	NULL
AIDS	NULL
(	NULL
Phila	NULL
.	NULL
)	NULL

5	NULL
,	NULL
497-508	NULL
28	NULL
.	NULL

Brenner	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
O'Hara	NULL
,	NULL
M.	NULL
,	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
Chojkier	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
887	NULL
,	NULL
661-663	NULL
29	NULL
.	NULL

Devary	NULL
,	NULL
Y.	NULL
,	NULL
Gottlieb	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Lau	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
2804-2811	NULL
30	NULL
.	NULL

Datta	NULL
,	NULL
R.	NULL
,	NULL
Hallahan	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Kbarbanda	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Rubin	NULL
,	NULL
E.	NULL
,	NULL
Sherman	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Huberman	NULL
,	NULL
E.	NULL
,	NULL
Weichselbaum	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
W.	NULL
(	NULL
1992	NULL
)	NULL
Biochemistry	NULL
31	NULL
,	NULL
8300-8306	NULL
31	NULL
.	NULL

Mufoz	NULL
,	NULL
E.	NULL
,	NULL
Zubiaga	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
and	NULL
Huber	NULL
,	NULL
B.	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

22	NULL
,	NULL
2101-2106	NULL
382	NULL
.	NULL

Aragonés	NULL
,	NULL
J.	NULL
,	NULL
Lépez-Rodriguez	NULL
,	NULL
C.	NULL
,	NULL
Corbi	NULL
,	NULL
A.	NULL
,	NULL
Gomez	NULL
del	NULL
Arco	NULL
,	NULL
P.	NULL
,	NULL
Lépez-Cabrera	NULL
,	NULL
M.	NULL
,	NULL
de	NULL
Land	NULL
&	NULL
zuri	NULL
,	NULL
M.	NULL
O.	NULL
,	NULL
and	NULL
Redondo	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
10924-10931	NULL
33	NULL
.	NULL

Spits	NULL
,	NULL
H.	NULL
,	NULL
Yssel	NULL
,	NULL
H.	NULL
,	NULL
Leeuwenberg	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
De	NULL
Vries	NULL
,	NULL
J.	NULL
E.	NULL
(	NULL
1985	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

15	NULL
,	NULL
88-91	NULL
34	NULL
.	NULL

Rohan	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Davis	NULL
,	NULL
P.	NULL
,	NULL
Moskaluk	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Kearns	NULL
,	NULL
M.	NULL
,	NULL
Krutzsch	NULL
,	NULL
H.	NULL
,	NULL
Siebenlist	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Kelly	NULL
,	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
259	NULL
,	NULL
1763-1766	NULL
35	NULL
.	NULL

Mizushima	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Nagata	NULL
,	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18	NULL
,	NULL
5822	NULL
36	NULL
.	NULL

Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Shaw	NULL
,	NULL
J.-P.	NULL
,	NULL
Bush	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Replogle	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Belagaje	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
1715-1724	NULL
37	NULL
.	NULL

Deng	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
479-490	NULL
38	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Muller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6419	NULL
39	NULL
.	NULL

Lisbona	NULL
,	NULL
C.	NULL
,	NULL
Alemany	NULL
,	NULL
S.	NULL
,	NULL
Calvo	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Ferngndez-Renart	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

24	NULL
,	NULL
2746-2754	NULL
40	NULL
.	NULL

Hibi	NULL
,	NULL
M.	NULL
,	NULL
Lin	NULL
,	NULL
A.	NULL
,	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
Minden	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
2135-2148	NULL
41	NULL
.	NULL

Leevers	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
and	NULL
Marshall	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
569-574	NULL
42	NULL
.	NULL

Ward	NULL
,	NULL
Y.	NULL
,	NULL
Gupta	NULL
,	NULL
S.	NULL
,	NULL
Jensen	NULL
,	NULL
P.	NULL
,	NULL
Wartmann	NULL
,	NULL
M.	NULL
,	NULL
Davis	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Kelly	NULL
,	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
867	NULL
,	NULL
651-654	NULL
48	NULL
.	NULL

Su	NULL
,	NULL
B.	NULL
,	NULL
Jacinto	NULL
,	NULL
E.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Kallunki	NULL
,	NULL
T.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Ben-Neriah	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cell	NULL
77	NULL
,	NULL
727-736	NULL
44	NULL
.	NULL

Livingstone	NULL
,	NULL
C.	NULL
,	NULL
Patel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Jones	NULL
,	NULL
N.	NULL
(	NULL
1995	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

14	NULL
,	NULL
1785-1797	NULL
45.	NULL
van	NULL
Dam	NULL
,	NULL
H.	NULL
,	NULL
Wilhelm	NULL
,	NULL
D.	NULL
,	NULL
Herr	NULL
,	NULL
L.	NULL
,	NULL
Steffen	NULL
,	NULL
A.	NULL
,	NULL
Herrlich	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Angel	NULL
,	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

14	NULL
,	NULL
1798-1811	NULL
46	NULL
.	NULL

Toullec	NULL
,	NULL
D.	NULL
,	NULL
Pianetti	NULL
,	NULL
P.	NULL
,	NULL
Coste	NULL
,	NULL
H.	NULL
,	NULL
Bellevergue	NULL
,	NULL
P.	NULL
,	NULL
Grand-Perret	NULL
,	NULL
T.	NULL
,	NULL
Ajakane	NULL
,	NULL
M.	NULL
,	NULL
Baudet	NULL
,	NULL
V.	NULL
,	NULL
Boissin	NULL
,	NULL
P.	NULL
,	NULL
Boursier	NULL
,	NULL
E.	NULL
,	NULL
Loriolle	NULL
,	NULL
F.	NULL
,	NULL
Duhamel	NULL
,	NULL
L.	NULL
,	NULL
Charon	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Kirilovsky	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
15771-15781	NULL
47	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Henkel	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12	NULL
,	NULL
141-179	NULL
48	NULL
.	NULL

Whitehurst	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
and	NULL
Geppert	NULL
,	NULL
T.	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

156	NULL
,	NULL
1020-1029	NULL
49	NULL
.	NULL

Liu	NULL
,	NULL
Y.	NULL
,	NULL
Gorospe	NULL
,	NULL
M.	NULL
,	NULL
Yang	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Holbrook	NULL
,	NULL
N.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
8377-8380	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
JNK	NULL
(	NULL
c-Jun	NULL
NH-terminal	NULL
Kinase	NULL
)	NULL
Is	NULL
a	NULL
Target	NULL
for	NULL
Antioxidants	NULL
in	NULL
T	NULL
Lymphocytes	NULL
Pablo	NULL
Gomez	NULL
Arco	NULL
,	NULL
Sara	NULL
Martinez-Martinez	NULL
,	NULL
Victor	NULL
Calvo	NULL
,	NULL
Angel	NULL
Luis	NULL
Armesilla	NULL
and	NULL
Juan	NULL
Miguel	NULL
Redondo	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1996	NULL
,	NULL
271:26335-26340.	NULL
doi	NULL
:	NULL
10.1074/jb0.271.42.26335	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/271/42/26335	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
49	NULL
references	NULL
,	NULL
17	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
.	NULL

full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

